IRAK4
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| O00151 | S31 | Sugiyama | PDLIM1 CLIM1 CLP36 | PGPWGFRLVGGKDFEQPLAIsRVtPGSKAALANLCIGDVIT |
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O14979 | T165 | Sugiyama | HNRNPDL HNRPDL JKTBP | QDDGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVT |
| O15212 | T84 | Sugiyama | PFDN6 HKE2 PFD6 | LVKQELGEARAtVGKRLDyItAEIKRYESQLRDLERQsEQQ |
| O43399 | S145 | Sugiyama | TPD52L2 | LyKKTQETLsQAGQKtsAALstVGsAIsRKLGDMRNsAtFK |
| O43399 | S152 | Sugiyama | TPD52L2 | TLsQAGQKtsAALstVGsAIsRKLGDMRNsAtFKsFEDRVG |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O60739 | T43 | Sugiyama | EIF1B | LPAGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAF |
| O60739 | T45 | Sugiyama | EIF1B | AGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKK |
| O60739 | T46 | Sugiyama | EIF1B | GTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKKK |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O60925 | S78 | Sugiyama | PFDN1 PFD1 | TNMYEGVGRMFILQSKEAIHsQLLEKQKIAEEKIKELEQKK |
| O75347 | S103 | Sugiyama | TBCA | ENEKDLEEAEEyKEARLVLDsVKLEA_______________ |
| O75821 | T190 | Sugiyama | EIF3G EIF3S4 | PYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNKt |
| O95218 | T50 | Sugiyama | ZRANB2 ZIS ZNF265 | SCNRCGREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQ |
| O95218 | T55 | Sugiyama | ZRANB2 ZIS ZNF265 | GREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQCKTCs |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| P00338 | S105 | Sugiyama | LDHA PIG19 | VTANsKLVIItAGARQQEGEsRLNLVQRNVNIFKFIIPNVV |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P04792 | S86 | Sugiyama | HSPB1 HSP27 HSP28 | PAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNHFAP |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05455 | T379 | Sugiyama | SSB | GKKtKFAsDDEHDEHDENGAtGPVKRAREEtDKEEPASKQQ |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P07195 | S106 | Sugiyama | LDHB | VtANSKIVVVtAGVRQQEGEsRLNLVQRNVNVFKFIIPQIV |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07237 | S449 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | ANEVEAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKF |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T10 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ___________MAQVLRGtVtDFPGFDERADAEtLRKAMKG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09496 | S236 | Sugiyama | CLTA | RLCDFNPKSSKQAKDVSRMRsVLIsLKQAPLVH________ |
| P09496 | S240 | Sugiyama | CLTA | FNPKSSKQAKDVSRMRsVLIsLKQAPLVH____________ |
| P09661 | S226 | Sugiyama | SNRPA1 | NAIANAstLAEVERLKGLLQsGQIPGRERRsGPtDDGEEEM |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10412 | S41 | Sugiyama | H1-4 H1F4 HIST1H1E | KKKARKsAGAAKRKAsGPPVsELItKAVAASKERsGVsLAA |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P10412 | S89 | Sugiyama | H1-4 H1F4 HIST1H1E | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P10412 | T45 | Sugiyama | H1-4 H1F4 HIST1H1E | RKsAGAAKRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13984 | T16 | Sugiyama | GTF2F2 RAP30 | _____MAERGELDLTGAKQNtGVWLVKVPKYLsQQWAKASG |
| P14598 | S288 | SIGNOR|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | KDDVTGYFPSMyLQKsGQDVsQAQRQIKRGAPPRRssIRNA |
| P14598 | S320 | SIGNOR|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | PRRssIRNAHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQAR |
| P14598 | S345 | SIGNOR|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | RRNsVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAV |
| P14598 | S348 | EPSD|PSP | NCF1 NOXO2 SH3PXD1A | sVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAVPPR |
| P14598 | S359 | EPSD|PSP | NCF1 NOXO2 SH3PXD1A | ARPGPQsPGsPLEEERQtQRsKPQPAVPPRPsADLILNRCs |
| P14598 | S370 | EPSD|PSP | NCF1 NOXO2 SH3PXD1A | LEEERQtQRsKPQPAVPPRPsADLILNRCsESTKRKLASAV |
| P14598 | T133 | SIGNOR|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | HLLDFFKVRPDDLKLPTDNQtKKPEtYLMPKDGKSTATDIt |
| P14598 | T138 | EPSD|PSP | NCF1 NOXO2 SH3PXD1A | FKVRPDDLKLPTDNQtKKPEtYLMPKDGKSTATDItGPIIL |
| P14598 | T153 | EPSD|PSP | NCF1 NOXO2 SH3PXD1A | tKKPEtYLMPKDGKSTATDItGPIILQTYRAIANYEKTSGS |
| P14598 | T356 | SIGNOR|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | RRQARPGPQsPGsPLEEERQtQRsKPQPAVPPRPsADLILN |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | T195 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | yVDDGLISLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAA |
| P14618 | T454 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SGRSAHQVARYRPRAPIIAVtRNPQtARQAHLYRGIFPVLC |
| P14618 | T459 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | HQVARYRPRAPIIAVtRNPQtARQAHLYRGIFPVLCKDPVQ |
| P14625 | S172 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSELI |
| P14625 | T675 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | sGNMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIR |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P16401 | S92 | Sugiyama | H1-5 H1F5 HIST1H1B | GGYDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16402 | S42 | Sugiyama | H1-3 H1F3 HIST1H1D | KKAKKAGATAGKRKAsGPPVsELItKAVAASKERsGVsLAA |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16402 | S90 | Sugiyama | H1-3 H1F3 HIST1H1D | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16402 | T46 | Sugiyama | H1-3 H1F3 HIST1H1D | KAGATAGKRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P16403 | S41 | Sugiyama | H1-2 H1F2 HIST1H1C | KKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsGVsLAA |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | S89 | Sugiyama | H1-2 H1F2 HIST1H1C | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16403 | T45 | Sugiyama | H1-2 H1F2 HIST1H1C | AKKAGGtPRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18621 | T12 | Sugiyama | RPL17 | _________MVRysLDPENPtKsCKSRGSNLRVHFKNtRET |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P20290 | S126 | Sugiyama | BTF3 NACB OK/SW-cl.8 | VNMFTNQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEM |
| P20290 | T131 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsIL |
| P20290 | T133 | Sugiyama | BTF3 NACB OK/SW-cl.8 | GTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQ |
| P20290 | T135 | Sugiyama | BTF3 NACB OK/SW-cl.8 | VIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQLG |
| P20290 | T140 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQLGADsLt |
| P22626 | T140 | Sugiyama | HNRNPA2B1 HNRPA2B1 | KEDTEEHHLRDyFEEYGKIDtIEIItDRQsGKKRGFGFVtF |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | S440 | Sugiyama | MAP4 | QANDIISSTEISSAEKVALssETEVALARDMtLPPETNVIL |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | T129 | Sugiyama | EEF1D EF1D | EARLNVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPA |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30086 | S99 | Sugiyama | PEBP1 PBP PEBP | PKYREWHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHR |
| P30086 | T51 | Sugiyama | PEBP1 PBP PEBP | GAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDP |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P31327 | T326 | Sugiyama | CPS1 | AKTYKMSMANRGQNQPVLNItNKQAFITAQNHGYALDNTLP |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35269 | S449 | Sugiyama | GTF2F1 RAP74 | PQsLsGKstPQPPsGKttPNsGDVQVTEDAVRRYLTRKPMT |
| P35579 | S1915 | Sugiyama | MYH9 | KLQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMA |
| P35579 | T1745 | Sugiyama | MYH9 | RRLEARIAQLEEELEEEQGNtELINDRLKKANLQIDQINtD |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S94 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | QAPVKKIQAstMAFKQMEQIsQFLQAAERYGINTTDIFQtV |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | T60 | Sugiyama | RPS19 | AKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIYG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P41567 | T43 | Sugiyama | EIF1 SUI1 | LPAGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAF |
| P41567 | T45 | Sugiyama | EIF1 SUI1 | AGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKK |
| P41567 | T46 | Sugiyama | EIF1 SUI1 | GTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKKK |
| P42766 | T59 | Sugiyama | RPL35 | GAASKLsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyK |
| P42766 | T64 | Sugiyama | RPL35 | LsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyKPLDLR |
| P46776 | S106 | Sugiyama | RPL27A | tRVNAAKNKtGAAPIIDVVRsGyyKVLGKGKLPKQPVIVKA |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46776 | Y108 | Sugiyama | RPL27A | VNAAKNKtGAAPIIDVVRsGyyKVLGKGKLPKQPVIVKAKF |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46779 | S91 | Sugiyama | RPL28 | RKPAtsyVRttINKNARAtLsSIRHMIRKNKYRPDLRMAAI |
| P46779 | T75 | Sugiyama | RPL28 | ADGKGVVVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRH |
| P46779 | T80 | Sugiyama | RPL28 | VVVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKN |
| P46779 | T81 | Sugiyama | RPL28 | VVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKNK |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P47914 | T151 | Sugiyama | RPL29 | DQTKAQAAAPAsVPAQAPKRtQAPtKAsE____________ |
| P47914 | T155 | Sugiyama | RPL29 | AQAAAPAsVPAQAPKRtQAPtKAsE________________ |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P51617 | S376 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | IRAK1 IRAK | LGDFGLARFSRFAGssPsQssMVARTQTVRGtLAyLPEEyI |
| P51617 | T387 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | IRAK1 IRAK | FAGssPsQssMVARTQTVRGtLAyLPEEyIKtGRLAVDTDT |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S9 | Sugiyama | SUB1 PC4 RPO2TC1 | ____________MPKSKELVsssssGsDsDsEVDKKLKRKK |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61254 | T93 | Sugiyama | RPL26 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| P61254 | T94 | Sugiyama | RPL26 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| P61513 | S21 | Sugiyama | RPL37A | MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAKYTCSF |
| P61513 | Y14 | Sugiyama | RPL37A | _______MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQH |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62316 | T26 | Sugiyama | SNRPD2 SNRPD1 | KPKsEMtPEELQKREEEEFNtGPLsVLtQsVKNNtQVLINC |
| P62316 | T33 | Sugiyama | SNRPD2 SNRPD1 | PEELQKREEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLL |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62750 | T42 | Sugiyama | RPL23A | LKAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPR |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62851 | S74 | Sugiyama | RPS25 | tyDKLCKEVPNYKLItPAVVsERLKIRGSLARAALQELLsK |
| P62857 | S41 | Sugiyama | RPS28 | tGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLLEs |
| P62857 | S61 | Sugiyama | RPS28 | sIIRNVKGPVREGDVLtLLEsEREARRLR____________ |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T107 | Sugiyama | RPL31 | RLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN__ |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | S167 | Sugiyama | YBX1 NSEP1 YB1 | RYPRRRGPPRNyQQNyQNsEsGEKNEGsEsAPEGQAQQRRP |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T126 | Sugiyama | YBX1 NSEP1 YB1 | GEtVEFDVVEGEKGAEAANVtGPGGVPVQGsKYAADRNHYR |
| P67809 | Y197 | Sugiyama | YBX1 NSEP1 YB1 | APEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGEV |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | T52 | Sugiyama | RPL24 | LNAKCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRT |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02539 | S92 | Sugiyama | H1-1 H1F1 HIST1H1A | AGyDVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNK |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q04760 | T35 | Sugiyama | GLO1 | AALSCCSDADPSTKDFLLQQtMLRVKDPKKSLDFyTRVLGM |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05682 | T169 | Sugiyama | CALD1 CAD CDM | KEEKsESRQERyEIEETEtVtKSYQKNDWRDAEENKKEDKE |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13442 | T97 | Sugiyama | PDAP1 HASPP28 | VEGLIDIENPNRVAQttKKVtQLDLDGPKELSRREREEIEK |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q13765 | S191 | Sugiyama | NACA HSD48 | VDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDIVNAIM |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | T1378 | Sugiyama | EIF3A EIF3S10 KIAA0139 | AEKDREsLRRTKNEtDEDGWttVRR________________ |
| Q14157 | T23 | Sugiyama | UBAP2L KIAA0144 NICE4 | TSVGTNRARGNWEQPQNQNQtQHKQRPQATAEQIRLAQMIS |
| Q14157 | T256 | Sugiyama | UBAP2L KIAA0144 NICE4 | AWRtAtEEWGtEDWNEDLsEtKIFtAsNVssVPLPAENVtI |
| Q14247 | S332 | Sugiyama | CTTN EMS1 | VQKDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRA |
| Q14247 | T145 | Sugiyama | CTTN EMS1 | FGVQMDRVDQsAVGFEyQGKtEKHAsQKDyssGFGGKyGVQ |
| Q14444 | S97 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | DYQERMNKGERLNQDQLDAVsKyQEVtNNLEFAKELQRsFM |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15084 | S230 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | QTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIFQKGEsPV |
| Q15084 | T223 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AAsEVKEQTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIF |
| Q15427 | T14 | Sugiyama | SF3B4 SAP49 | _______MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFL |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6FI81 | S305 | Sugiyama | CIAPIN1 CUA001 PRO0915 | CAsCPyLGMPAFKPGEKVLLsDsNLHDA_____________ |
| Q6P1R4 | T365 | Sugiyama | DUS1L DUS1 | GSKEKAGARSKRALEEEEGGtEVLSKNKQKKQLRNPHKTFD |
| Q6P996 | S721 | Sugiyama | PDXDC1 KIAA0251 | LPGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQ |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8N6T3 | S273 | Sugiyama | ARFGAP1 ARF1GAP | KPAQEKVKEGKIFDDVSsGVsQLAsKVQGVGSKGWRDVttF |
| Q8N6T3 | S277 | Sugiyama | ARFGAP1 ARF1GAP | EKVKEGKIFDDVSsGVsQLAsKVQGVGSKGWRDVttFFsGK |
| Q8N6T3 | T291 | Sugiyama | ARFGAP1 ARF1GAP | GVsQLAsKVQGVGSKGWRDVttFFsGKAEGPLDsPSEGHSy |
| Q8NBS9 | S426 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVSEHSGGRDLDSLHRFVLsQAKDEL______________ |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8WU90 | T348 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | sVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLs |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96B36 | T233 | Sugiyama | AKT1S1 PRAS40 | PDLDRIAAsMRALVLREAEDtQVFGDLPRPRLNtsDFQKLK |
| Q96FA3 | S293 | SIGNOR|EPSD|PSP | PELI1 PRISM | QEINAARPQCPVGFNtLAFPsMKRKDVVDEKQPWVYLNCGH |
| Q96FA3 | S70 | EPSD|PSP | PELI1 PRISM | NGVKPSTVHIACTPQAAKAIsNKDQHsIsYtLsRAQtVVVE |
| Q96FA3 | S76 | SIGNOR|EPSD|PSP | PELI1 PRISM | TVHIACTPQAAKAIsNKDQHsIsYtLsRAQtVVVEYTHDSN |
| Q96FA3 | S78 | SIGNOR|EPSD|PSP | PELI1 PRISM | HIACTPQAAKAIsNKDQHsIsYtLsRAQtVVVEYTHDSNTD |
| Q96FA3 | S82 | SIGNOR|EPSD|PSP | PELI1 PRISM | TPQAAKAIsNKDQHsIsYtLsRAQtVVVEYTHDSNTDMFQI |
| Q96FA3 | T127 | EPSD|PSP | PELI1 PRISM | ESPIDFVVTDTVPGSQSNsDtQSVQSTISRFACRIICERNP |
| Q96FA3 | T288 | SIGNOR|EPSD|PSP | PELI1 PRISM | LEALRQEINAARPQCPVGFNtLAFPsMKRKDVVDEKQPWVY |
| Q96FA3 | T80 | SIGNOR|EPSD|PSP | PELI1 PRISM | ACTPQAAKAIsNKDQHsIsYtLsRAQtVVVEYTHDSNTDMF |
| Q96FA3 | T86 | SIGNOR|EPSD|PSP | PELI1 PRISM | AKAIsNKDQHsIsYtLsRAQtVVVEYTHDSNTDMFQIGRST |
| Q96IZ0 | S259 | Sugiyama | PAWR PAR4 | SRYsRTDRSGFPRYNRDANVsGtLVSSstLEKKIEDLEKEV |
| Q96JH7 | S1079 | Sugiyama | VCPIP1 KIAA1850 VCIP135 | DFSNSsTKTEPSVFTASSsNsELIRIAPGVVTMRDGRQLDP |
| Q99460 | T830 | Sugiyama | PSMD1 | TFAYPAPLEVPKEKEKEKVStAVLsItAKAKKKEKEKEKKE |
| Q99460 | T836 | Sugiyama | PSMD1 | PLEVPKEKEKEKVStAVLsItAKAKKKEKEKEKKEEEKMEV |
| Q99614 | S155 | Sugiyama | TTC1 TPR1 | AESSYSRALEMCPSCFQKERsILFSNRAAARMKQDKKEMAI |
| Q99848 | S269 | Sugiyama | EBNA1BP2 EBP2 | GFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGS |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9H1E3 | S14 | Sugiyama | NUCKS1 NUCKS JC7 | _______MSRPVRNRKVVDysQFQEsDDADEDyGRDsGPPt |
| Q9H1E3 | T34 | Sugiyama | NUCKS1 NUCKS JC7 | sQFQEsDDADEDyGRDsGPPtKKIRSsPREAKNKRRsGKNs |
| Q9H444 | T103 | Sugiyama | CHMP4B C20orf178 SHAX1 | DGtLstIEFQREALENANtNtEVLKNMGYAAKAMKAAHDNM |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NVS9 | T111 | Sugiyama | PNPO | KPSARMLLLKGFGKDGFRFFtNFESRKGKELDSNPFASLVF |
| Q9NWZ3 | S114 | EPSD|PSP|Sugiyama | IRAK4 | FAPASLLLPDAVPKTANTLPsKEAItVQQKQMPFCDKDRTL |
| Q9NWZ3 | S150 | EPSD|PSP | IRAK4 | KDRTLMTPVQNLEQSYMPPDsssPENKsLEVSDTRFHSFSF |
| Q9NWZ3 | S151 | EPSD|PSP | IRAK4 | DRTLMTPVQNLEQSYMPPDsssPENKsLEVSDTRFHSFSFY |
| Q9NWZ3 | S152 | EPSD|PSP | IRAK4 | RTLMTPVQNLEQSYMPPDsssPENKsLEVSDTRFHSFSFYE |
| Q9NWZ3 | S186 | Sugiyama | IRAK4 | HSFSFYELKNVtNNFDERPIsVGGNKMGEGGFGVVYKGYVN |
| Q9NWZ3 | S314 | Sugiyama | IRAK4 | GAANGINFLHENHHIHRDIKsANILLDEAFtAKISDFGLAR |
| Q9NWZ3 | S346 | GPS6|SIGNOR|EPSD|PSP | IRAK4 | KISDFGLARASEKFAQtVMtsRIVGTtAYMAPEALRGEITP |
| Q9NWZ3 | S8 | EPSD|PSP | IRAK4 | _____________MNKPItPsTYVRCLNVGLIRKLSDFIDP |
| Q9NWZ3 | T119 | Sugiyama | IRAK4 | LLLPDAVPKTANTLPsKEAItVQQKQMPFCDKDRTLMTPVQ |
| Q9NWZ3 | T177 | Sugiyama | IRAK4 | sLEVSDTRFHSFSFYELKNVtNNFDERPIsVGGNKMGEGGF |
| Q9NWZ3 | T208 | EPSD|PSP|Sugiyama | IRAK4 | GGNKMGEGGFGVVYKGYVNNttVAVKKLAAMVDITtEELKQ |
| Q9NWZ3 | T209 | EPSD|PSP|Sugiyama | IRAK4 | GNKMGEGGFGVVYKGYVNNttVAVKKLAAMVDITtEELKQQ |
| Q9NWZ3 | T223 | Sugiyama | IRAK4 | GYVNNttVAVKKLAAMVDITtEELKQQFDQEIKVMAKCQHE |
| Q9NWZ3 | T324 | Sugiyama | IRAK4 | ENHHIHRDIKsANILLDEAFtAKISDFGLARASEKFAQtVM |
| Q9NWZ3 | T342 | GPS6|SIGNOR|EPSD|PSP | IRAK4 | AFtAKISDFGLARASEKFAQtVMtsRIVGTtAYMAPEALRG |
| Q9NWZ3 | T345 | GPS6|SIGNOR|EPSD|PSP | IRAK4 | AKISDFGLARASEKFAQtVMtsRIVGTtAYMAPEALRGEIT |
| Q9NWZ3 | T352 | EPSD|PSP | IRAK4 | LARASEKFAQtVMtsRIVGTtAYMAPEALRGEITPKSDIYS |
| Q9NWZ3 | T6 | EPSD|PSP | IRAK4 | _______________MNKPItPsTYVRCLNVGLIRKLSDFI |
| Q9NWZ3 | T62 | Sugiyama | IRAK4 | PSGDDRYNQFHIRRFEALLQtGKSPTSELLFDWGTTNCTVG |
| Q9UHV9 | S22 | Sugiyama | PFDN2 PFD2 HSPC231 | AENSGRAGKssGSGAGKGAVsAEQVIAGFNRLRQEQRGLAS |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UMX5 | T130 | Sugiyama | NENF CIR2 SPUF | LTHDTTGLTAKELEALDEVFtKVYKAKYPIVGYTARRILNE |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UNX3 | T93 | Sugiyama | RPL26L1 RPL26P1 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| Q9UNX3 | T94 | Sugiyama | RPL26L1 RPL26P1 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| Q9Y266 | T145 | Sugiyama | NUDC | AENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKLKPNLGN |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2V2 | T45 | Sugiyama | CARHSP1 | RsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKG |
| Q9Y2V2 | T48 | Sugiyama | CARHSP1 | ERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKGVCK |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y608 | S25 | Sugiyama | LRRFIP2 | ASGRKRTPVKDRFsAEDEALsNIAREAEARLAAKRAARAEA |
| Q9Y6W5 | S442 | Sugiyama | WASF2 WAVE2 | DTTKPKSSLPAVSDARSDLLsAIRQGFQLRRVEEQREQEKR |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 4.888645e-12 | 11.311 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 9.383494e-12 | 11.028 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.346376e-09 | 8.272 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.175280e-09 | 8.087 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.975835e-07 | 6.401 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.708916e-06 | 5.767 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.611038e-06 | 5.583 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.920186e-06 | 5.308 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.529771e-06 | 5.257 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.375732e-06 | 5.132 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.071186e-06 | 5.042 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 9.528265e-06 | 5.021 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.966578e-06 | 5.001 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.312207e-05 | 4.882 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.477366e-05 | 4.831 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.574221e-05 | 4.803 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.733261e-05 | 4.563 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.898245e-05 | 4.538 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.573429e-05 | 4.447 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.866914e-05 | 4.413 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.228616e-05 | 4.374 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.181730e-05 | 4.379 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.678096e-05 | 4.330 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.730005e-05 | 4.325 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.132261e-05 | 4.212 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.950986e-05 | 4.158 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.178347e-05 | 4.144 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.155730e-05 | 4.089 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 9.617269e-05 | 4.017 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.157422e-04 | 3.937 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.157422e-04 | 3.937 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.137106e-04 | 3.944 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.157422e-04 | 3.937 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.523617e-04 | 3.817 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.515599e-04 | 3.819 | 1 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.574549e-04 | 3.803 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.688846e-04 | 3.772 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.688846e-04 | 3.772 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.893336e-04 | 3.723 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.879865e-04 | 3.726 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.787575e-04 | 3.748 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.962185e-04 | 3.707 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.182625e-04 | 3.661 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.742942e-04 | 3.562 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.079052e-04 | 3.512 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.079052e-04 | 3.512 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.152321e-04 | 3.501 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.431799e-04 | 3.464 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.795051e-04 | 3.421 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.269634e-04 | 3.370 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.628900e-04 | 3.335 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.628900e-04 | 3.335 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.600925e-04 | 3.337 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.449535e-04 | 3.352 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.600925e-04 | 3.337 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.028046e-04 | 3.299 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.311939e-04 | 3.275 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.343479e-04 | 3.272 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.343479e-04 | 3.272 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.960806e-04 | 3.225 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.249583e-04 | 3.204 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.156880e-04 | 3.211 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.106536e-04 | 3.214 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 6.252542e-04 | 3.204 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.316407e-04 | 3.200 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.316407e-04 | 3.200 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.316407e-04 | 3.200 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.627595e-04 | 3.179 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.106720e-04 | 3.091 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.193047e-04 | 3.037 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.856679e-04 | 3.006 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.838141e-04 | 3.007 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 9.920685e-04 | 3.003 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.093937e-03 | 2.961 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.143740e-03 | 2.942 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.143075e-03 | 2.942 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.184108e-03 | 2.927 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.337502e-03 | 2.874 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.418088e-03 | 2.848 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.569663e-03 | 2.804 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.566146e-03 | 2.805 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.576422e-03 | 2.802 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.499336e-03 | 2.824 | 1 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.648476e-03 | 2.783 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.648476e-03 | 2.783 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.675429e-03 | 2.776 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.716747e-03 | 2.765 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.029194e-03 | 2.693 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.029194e-03 | 2.693 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.029194e-03 | 2.693 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.029194e-03 | 2.693 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.029194e-03 | 2.693 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.029194e-03 | 2.693 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.029194e-03 | 2.693 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.029194e-03 | 2.693 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.029194e-03 | 2.693 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.029194e-03 | 2.693 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.029194e-03 | 2.693 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.164183e-03 | 2.665 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.164183e-03 | 2.665 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.164183e-03 | 2.665 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.164183e-03 | 2.665 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.086990e-03 | 2.680 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.083603e-03 | 2.681 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.968640e-03 | 2.706 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.200381e-03 | 2.658 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.200381e-03 | 2.658 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.528007e-03 | 2.597 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.528007e-03 | 2.597 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.463134e-03 | 2.609 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.360902e-03 | 2.627 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.467837e-03 | 2.608 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.698739e-03 | 2.569 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.719216e-03 | 2.566 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.797674e-03 | 2.553 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.890788e-03 | 2.539 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.917641e-03 | 2.535 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.176476e-03 | 2.498 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.040191e-03 | 2.517 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.055968e-03 | 2.515 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.193725e-03 | 2.496 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.257534e-03 | 2.487 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.322116e-03 | 2.479 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.322116e-03 | 2.479 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.322116e-03 | 2.479 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.322116e-03 | 2.479 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.322116e-03 | 2.479 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.322116e-03 | 2.479 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.322116e-03 | 2.479 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.987007e-03 | 2.399 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.877521e-03 | 2.411 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.268453e-03 | 2.370 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.268453e-03 | 2.370 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.408346e-03 | 2.356 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.472477e-03 | 2.349 | 1 | 1 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.996224e-03 | 2.301 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.996224e-03 | 2.301 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.842160e-03 | 2.315 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.585115e-03 | 2.339 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.959908e-03 | 2.305 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.912603e-03 | 2.309 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.996224e-03 | 2.301 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.710531e-03 | 2.327 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.971413e-03 | 2.304 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.318443e-03 | 2.274 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.446461e-03 | 2.264 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.457447e-03 | 2.263 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.514034e-03 | 2.259 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.747504e-03 | 2.171 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.747504e-03 | 2.171 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.747504e-03 | 2.171 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.765219e-03 | 2.170 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.765219e-03 | 2.170 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.765219e-03 | 2.170 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.765219e-03 | 2.170 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.102840e-03 | 2.214 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.744240e-03 | 2.171 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.747504e-03 | 2.171 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.392031e-03 | 2.194 | 1 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.415988e-03 | 2.193 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.850405e-03 | 2.164 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 6.894115e-03 | 2.162 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 6.894115e-03 | 2.162 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 6.894115e-03 | 2.162 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 6.894115e-03 | 2.162 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 6.894115e-03 | 2.162 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.943991e-03 | 2.158 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.945628e-03 | 2.158 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.296279e-03 | 2.137 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.423365e-03 | 2.129 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.214631e-03 | 2.085 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.214631e-03 | 2.085 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.494554e-03 | 2.071 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.909888e-03 | 2.102 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.257902e-03 | 2.083 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.500069e-03 | 2.071 | 1 | 1 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.500069e-03 | 2.071 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.500069e-03 | 2.071 | 1 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.316355e-03 | 2.080 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.554006e-03 | 2.068 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.668343e-03 | 2.062 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.863110e-03 | 2.052 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 8.863110e-03 | 2.052 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.863110e-03 | 2.052 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.219024e-03 | 2.035 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.241878e-03 | 2.034 | 1 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.241878e-03 | 2.034 | 1 | 1 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.556761e-03 | 2.020 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.818545e-03 | 2.008 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.011417e-02 | 1.995 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.123785e-02 | 1.949 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.114759e-02 | 1.953 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.070105e-02 | 1.971 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.123785e-02 | 1.949 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.120649e-02 | 1.951 | 1 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.048991e-02 | 1.979 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.120649e-02 | 1.951 | 1 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.011417e-02 | 1.995 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.114759e-02 | 1.953 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.133502e-02 | 1.946 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.137019e-02 | 1.944 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.137019e-02 | 1.944 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.137019e-02 | 1.944 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.137019e-02 | 1.944 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.137019e-02 | 1.944 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.171464e-02 | 1.931 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.215247e-02 | 1.915 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.215247e-02 | 1.915 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.215247e-02 | 1.915 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.237874e-02 | 1.907 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.299641e-02 | 1.886 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.420879e-02 | 1.847 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.428388e-02 | 1.845 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.429262e-02 | 1.845 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.429262e-02 | 1.845 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.429262e-02 | 1.845 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.445261e-02 | 1.840 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.454587e-02 | 1.837 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.454587e-02 | 1.837 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.485247e-02 | 1.828 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.489613e-02 | 1.827 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.490088e-02 | 1.827 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.490088e-02 | 1.827 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 1.490088e-02 | 1.827 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.497263e-02 | 1.825 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.613427e-02 | 1.792 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.613427e-02 | 1.792 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.606794e-02 | 1.794 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.747020e-02 | 1.758 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.702779e-02 | 1.769 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.726882e-02 | 1.763 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.765091e-02 | 1.753 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.765761e-02 | 1.753 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.765761e-02 | 1.753 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.784422e-02 | 1.749 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.799277e-02 | 1.745 | 1 | 1 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.800438e-02 | 1.745 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.847401e-02 | 1.733 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.871207e-02 | 1.728 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.871207e-02 | 1.728 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.871207e-02 | 1.728 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.911787e-02 | 1.719 | 1 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.914675e-02 | 1.718 | 1 | 1 |
| Inflammasomes | R-HSA-622312 | 1.949143e-02 | 1.710 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.989010e-02 | 1.701 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.009922e-02 | 1.697 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.146213e-02 | 1.668 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 2.545256e-02 | 1.594 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 2.545256e-02 | 1.594 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 2.545256e-02 | 1.594 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.545256e-02 | 1.594 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.424181e-02 | 1.615 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.424181e-02 | 1.615 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.424181e-02 | 1.615 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.305038e-02 | 1.637 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.305038e-02 | 1.637 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.305038e-02 | 1.637 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.651827e-02 | 1.576 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.651827e-02 | 1.576 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.562694e-02 | 1.591 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.396138e-02 | 1.620 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.431358e-02 | 1.614 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.413035e-02 | 1.617 | 1 | 1 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.577396e-02 | 1.589 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 2.545256e-02 | 1.594 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 2.424181e-02 | 1.615 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.432923e-02 | 1.614 | 1 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.374897e-02 | 1.624 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.478695e-02 | 1.606 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.417020e-02 | 1.617 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.706365e-02 | 1.568 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.739050e-02 | 1.562 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.778909e-02 | 1.556 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.778909e-02 | 1.556 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.787964e-02 | 1.555 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.787964e-02 | 1.555 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.885255e-02 | 1.540 | 1 | 0 |
| S Phase | R-HSA-69242 | 2.982467e-02 | 1.525 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.982467e-02 | 1.525 | 1 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.985786e-02 | 1.525 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.049456e-02 | 1.516 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.049456e-02 | 1.516 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 3.049456e-02 | 1.516 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.049456e-02 | 1.516 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.049456e-02 | 1.516 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.064780e-02 | 1.514 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.067546e-02 | 1.513 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.084833e-02 | 1.511 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.093390e-02 | 1.510 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.113256e-02 | 1.507 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.152782e-02 | 1.501 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.163846e-02 | 1.500 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.180673e-02 | 1.497 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.821956e-02 | 1.418 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.835037e-02 | 1.416 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.440874e-02 | 1.463 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.440874e-02 | 1.463 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.884395e-02 | 1.411 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.884395e-02 | 1.411 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.314118e-02 | 1.480 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.709866e-02 | 1.431 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.884395e-02 | 1.411 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.314118e-02 | 1.480 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.488425e-02 | 1.457 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.462355e-02 | 1.461 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.462355e-02 | 1.461 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.309119e-02 | 1.480 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.314118e-02 | 1.480 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.936236e-02 | 1.405 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.835037e-02 | 1.416 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.440874e-02 | 1.463 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.462355e-02 | 1.461 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 3.835037e-02 | 1.416 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.462355e-02 | 1.461 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.673333e-02 | 1.435 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.069729e-02 | 1.390 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.069729e-02 | 1.390 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.884395e-02 | 1.411 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.884395e-02 | 1.411 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.034471e-02 | 1.394 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.111924e-02 | 1.386 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 4.145914e-02 | 1.382 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 4.145914e-02 | 1.382 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.175747e-02 | 1.379 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.233825e-02 | 1.373 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.233825e-02 | 1.373 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.318784e-02 | 1.365 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.356253e-02 | 1.361 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.361199e-02 | 1.360 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.383525e-02 | 1.358 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.406374e-02 | 1.356 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.656947e-02 | 1.332 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 4.666451e-02 | 1.331 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.666451e-02 | 1.331 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.666451e-02 | 1.331 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.714614e-02 | 1.327 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.714614e-02 | 1.327 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.871581e-02 | 1.312 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.871581e-02 | 1.312 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.937954e-02 | 1.306 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.036837e-02 | 1.298 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.043298e-02 | 1.297 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.093468e-02 | 1.293 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 5.933728e-02 | 1.227 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 5.933728e-02 | 1.227 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 5.933728e-02 | 1.227 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 5.933728e-02 | 1.227 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 5.933728e-02 | 1.227 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 5.933728e-02 | 1.227 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 5.933728e-02 | 1.227 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 5.933728e-02 | 1.227 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 5.933728e-02 | 1.227 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 5.933728e-02 | 1.227 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 5.933728e-02 | 1.227 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 5.933728e-02 | 1.227 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 5.933728e-02 | 1.227 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 5.933728e-02 | 1.227 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 5.933728e-02 | 1.227 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.290236e-02 | 1.277 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.290236e-02 | 1.277 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.290236e-02 | 1.277 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.290236e-02 | 1.277 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.922912e-02 | 1.160 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.578782e-02 | 1.253 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.155778e-02 | 1.211 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.921542e-02 | 1.160 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.921542e-02 | 1.160 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.921542e-02 | 1.160 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.921542e-02 | 1.160 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.921542e-02 | 1.160 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.921542e-02 | 1.160 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.415706e-02 | 1.266 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 5.415706e-02 | 1.266 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.681683e-02 | 1.246 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.353772e-02 | 1.271 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.317748e-02 | 1.274 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.317748e-02 | 1.274 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.605205e-02 | 1.180 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.317748e-02 | 1.274 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.437485e-02 | 1.265 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.437485e-02 | 1.265 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.415706e-02 | 1.266 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.078875e-02 | 1.216 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.579309e-02 | 1.253 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.922912e-02 | 1.160 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.568951e-02 | 1.183 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.949884e-02 | 1.158 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.155778e-02 | 1.211 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.155778e-02 | 1.211 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.922912e-02 | 1.160 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.605205e-02 | 1.180 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.578782e-02 | 1.253 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.860794e-02 | 1.164 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.604129e-02 | 1.180 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.501645e-02 | 1.260 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.373216e-02 | 1.270 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 6.922912e-02 | 1.160 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.005458e-02 | 1.155 | 1 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.922912e-02 | 1.160 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.437485e-02 | 1.265 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.922912e-02 | 1.160 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.415706e-02 | 1.266 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.155059e-02 | 1.145 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.155059e-02 | 1.145 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.183479e-02 | 1.144 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.250280e-02 | 1.140 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.251695e-02 | 1.140 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.365066e-02 | 1.133 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.377815e-02 | 1.132 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.377815e-02 | 1.132 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.633247e-02 | 1.117 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.633403e-02 | 1.117 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.633403e-02 | 1.117 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.633403e-02 | 1.117 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.633403e-02 | 1.117 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.633403e-02 | 1.117 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.633403e-02 | 1.117 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.633403e-02 | 1.117 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.731582e-02 | 1.112 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.844890e-02 | 1.105 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.844890e-02 | 1.105 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.882540e-02 | 1.103 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.296423e-02 | 1.081 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.329221e-02 | 1.079 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.330826e-02 | 1.079 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.420614e-02 | 1.075 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.151570e-01 | 0.939 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.151570e-01 | 0.939 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 1.151570e-01 | 0.939 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 1.151570e-01 | 0.939 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.151570e-01 | 0.939 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.151570e-01 | 0.939 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.151570e-01 | 0.939 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.151570e-01 | 0.939 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 8.695348e-02 | 1.061 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.695348e-02 | 1.061 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 8.695348e-02 | 1.061 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 8.695348e-02 | 1.061 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 8.695348e-02 | 1.061 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.058525e-01 | 0.975 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 1.257246e-01 | 0.901 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.257246e-01 | 0.901 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.768203e-02 | 1.057 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.768203e-02 | 1.057 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.768203e-02 | 1.057 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.768203e-02 | 1.057 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 9.969128e-02 | 1.001 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.123174e-01 | 0.950 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.255146e-01 | 0.901 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 1.255146e-01 | 0.901 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.255146e-01 | 0.901 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 9.493280e-02 | 1.023 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.639452e-02 | 1.064 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.244724e-01 | 0.905 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.015723e-01 | 0.993 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.960749e-02 | 1.048 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.099066e-01 | 0.959 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.099066e-01 | 0.959 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.179813e-01 | 0.928 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.179813e-01 | 0.928 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.349488e-02 | 1.029 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.539022e-02 | 1.020 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 1.043760e-01 | 0.981 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.960749e-02 | 1.048 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.073683e-01 | 0.969 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.266265e-01 | 0.897 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.695348e-02 | 1.061 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 8.695348e-02 | 1.061 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.695348e-02 | 1.061 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.257246e-01 | 0.901 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.591529e-02 | 1.066 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.100754e-01 | 0.958 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.960749e-02 | 1.048 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.164662e-01 | 0.934 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 1.123174e-01 | 0.950 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.112793e-02 | 1.040 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.244724e-01 | 0.905 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.096268e-01 | 0.960 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.558130e-02 | 1.020 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.159370e-01 | 0.936 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.255146e-01 | 0.901 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.102674e-01 | 0.958 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.141653e-01 | 0.942 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.695348e-02 | 1.061 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 1.257246e-01 | 0.901 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.077633e-01 | 0.968 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.275056e-01 | 0.894 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.275056e-01 | 0.894 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.275056e-01 | 0.894 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.275056e-01 | 0.894 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.123174e-01 | 0.950 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.382572e-02 | 1.028 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.200957e-01 | 0.920 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.349488e-02 | 1.029 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 8.591529e-02 | 1.066 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.639452e-02 | 1.064 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.112555e-01 | 0.954 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.768203e-02 | 1.057 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.244724e-01 | 0.905 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.119867e-01 | 0.951 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.255146e-01 | 0.901 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.539022e-02 | 1.020 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.151570e-01 | 0.939 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.151570e-01 | 0.939 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 8.695348e-02 | 1.061 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.493280e-02 | 1.023 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.077633e-01 | 0.968 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.159370e-01 | 0.936 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.244724e-01 | 0.905 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.275056e-01 | 0.894 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.004853e-01 | 0.998 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.123174e-01 | 0.950 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.493280e-02 | 1.023 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.981287e-02 | 1.001 | 1 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.257272e-01 | 0.901 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 1.257246e-01 | 0.901 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.558130e-02 | 1.020 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.159370e-01 | 0.936 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.244724e-01 | 0.905 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.244724e-01 | 0.905 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 1.171541e-01 | 0.931 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 1.171541e-01 | 0.931 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 1.257246e-01 | 0.901 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.128347e-01 | 0.948 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.236225e-02 | 1.035 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.058525e-01 | 0.975 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.123174e-01 | 0.950 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.123174e-01 | 0.950 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.210472e-01 | 0.917 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.257246e-01 | 0.901 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.015725e-01 | 0.993 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.056088e-02 | 1.043 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.591529e-02 | 1.066 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.695348e-02 | 1.061 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.257246e-01 | 0.901 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.096268e-01 | 0.960 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.281507e-01 | 0.892 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.305110e-01 | 0.884 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.322574e-01 | 0.879 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.344652e-01 | 0.871 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.344652e-01 | 0.871 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.350892e-01 | 0.869 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 1.350892e-01 | 0.869 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.350892e-01 | 0.869 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.350892e-01 | 0.869 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.355530e-01 | 0.868 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.355530e-01 | 0.868 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.363567e-01 | 0.865 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.363567e-01 | 0.865 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.367140e-01 | 0.864 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 1.367140e-01 | 0.864 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.392363e-01 | 0.856 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.392363e-01 | 0.856 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.392363e-01 | 0.856 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.402698e-01 | 0.853 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.402698e-01 | 0.853 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.405272e-01 | 0.852 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.410019e-01 | 0.851 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.416079e-01 | 0.849 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 1.438135e-01 | 0.842 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.447502e-01 | 0.839 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.453281e-01 | 0.838 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.460591e-01 | 0.835 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.463881e-01 | 0.834 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.463881e-01 | 0.834 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 1.463881e-01 | 0.834 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.463881e-01 | 0.834 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.463881e-01 | 0.834 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.463881e-01 | 0.834 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.476595e-01 | 0.831 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.479532e-01 | 0.830 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.484127e-01 | 0.829 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.534353e-01 | 0.814 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 1.534353e-01 | 0.814 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.534353e-01 | 0.814 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.534353e-01 | 0.814 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 1.542074e-01 | 0.812 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.542074e-01 | 0.812 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.558897e-01 | 0.807 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.559326e-01 | 0.807 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.568070e-01 | 0.805 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.573615e-01 | 0.803 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 1.573615e-01 | 0.803 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.573615e-01 | 0.803 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.573615e-01 | 0.803 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.573615e-01 | 0.803 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.579361e-01 | 0.802 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.588377e-01 | 0.799 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.609574e-01 | 0.793 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 1.676675e-01 | 0.776 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 1.676675e-01 | 0.776 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.676675e-01 | 0.776 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.676675e-01 | 0.776 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.676675e-01 | 0.776 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.676675e-01 | 0.776 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 1.676675e-01 | 0.776 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.676675e-01 | 0.776 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.676675e-01 | 0.776 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 1.676675e-01 | 0.776 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 2.170648e-01 | 0.663 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.170648e-01 | 0.663 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 2.170648e-01 | 0.663 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 2.170648e-01 | 0.663 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 2.170648e-01 | 0.663 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 2.170648e-01 | 0.663 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.170648e-01 | 0.663 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 2.635332e-01 | 0.579 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.635332e-01 | 0.579 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 2.635332e-01 | 0.579 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 2.635332e-01 | 0.579 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.635332e-01 | 0.579 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 1.676794e-01 | 0.776 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.072463e-01 | 0.513 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 3.072463e-01 | 0.513 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 3.072463e-01 | 0.513 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.072463e-01 | 0.513 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 3.072463e-01 | 0.513 | 0 | 0 |
| Defective MAT1A causes MATD | R-HSA-5579024 | 3.072463e-01 | 0.513 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.894514e-01 | 0.723 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.894514e-01 | 0.723 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.339242e-01 | 0.631 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.339242e-01 | 0.631 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.564018e-01 | 0.591 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.564018e-01 | 0.591 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.984297e-01 | 0.702 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.789118e-01 | 0.555 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.140748e-01 | 0.669 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.140748e-01 | 0.669 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.689756e-01 | 0.772 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.689756e-01 | 0.772 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.299700e-01 | 0.638 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.299700e-01 | 0.638 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.299700e-01 | 0.638 | 1 | 1 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.013711e-01 | 0.521 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.460732e-01 | 0.609 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.460732e-01 | 0.609 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.439832e-01 | 0.613 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.439832e-01 | 0.613 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.952350e-01 | 0.530 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.490009e-01 | 0.604 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 2.839248e-01 | 0.547 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.181133e-01 | 0.661 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.789118e-01 | 0.555 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.439832e-01 | 0.613 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.894514e-01 | 0.723 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.460732e-01 | 0.609 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.789118e-01 | 0.555 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.830781e-01 | 0.737 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.894514e-01 | 0.723 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.805627e-01 | 0.552 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.680647e-01 | 0.775 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.439832e-01 | 0.613 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.072463e-01 | 0.513 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.072463e-01 | 0.513 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 3.013711e-01 | 0.521 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.767556e-01 | 0.753 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.460732e-01 | 0.609 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.564018e-01 | 0.591 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.110662e-01 | 0.507 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.920938e-01 | 0.716 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.639129e-01 | 0.785 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.069008e-01 | 0.513 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 3.072463e-01 | 0.513 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.115723e-01 | 0.675 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 2.339242e-01 | 0.631 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 2.789118e-01 | 0.555 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.237066e-01 | 0.490 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 2.952350e-01 | 0.530 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.952350e-01 | 0.530 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.047636e-01 | 0.689 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.060217e-01 | 0.686 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.225365e-01 | 0.491 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.808797e-01 | 0.743 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.033123e-01 | 0.692 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.115723e-01 | 0.675 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.676794e-01 | 0.776 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.309581e-01 | 0.636 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.117830e-01 | 0.506 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.072463e-01 | 0.513 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.072463e-01 | 0.513 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.115723e-01 | 0.675 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.789118e-01 | 0.555 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.013711e-01 | 0.521 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 3.237066e-01 | 0.490 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.752903e-01 | 0.756 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.181133e-01 | 0.661 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 2.399758e-01 | 0.620 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.852302e-01 | 0.545 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.339242e-01 | 0.631 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.564018e-01 | 0.591 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.309581e-01 | 0.636 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.970758e-01 | 0.527 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.680647e-01 | 0.775 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.840210e-01 | 0.735 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.704877e-01 | 0.568 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.511741e-01 | 0.600 | 1 | 1 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 1.676675e-01 | 0.776 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.676675e-01 | 0.776 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 2.170648e-01 | 0.663 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 2.170648e-01 | 0.663 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 2.170648e-01 | 0.663 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 2.170648e-01 | 0.663 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.635332e-01 | 0.579 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.676794e-01 | 0.776 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.676794e-01 | 0.776 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 2.115723e-01 | 0.675 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 2.115723e-01 | 0.675 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.339242e-01 | 0.631 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.564018e-01 | 0.591 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.789118e-01 | 0.555 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.299700e-01 | 0.638 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.639129e-01 | 0.785 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.237066e-01 | 0.490 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.117830e-01 | 0.506 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.603706e-01 | 0.584 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.916357e-01 | 0.718 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.049498e-01 | 0.516 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.722873e-01 | 0.764 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 3.072463e-01 | 0.513 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.741424e-01 | 0.759 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.783525e-01 | 0.555 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 3.072463e-01 | 0.513 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.237066e-01 | 0.490 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.399758e-01 | 0.620 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.894514e-01 | 0.723 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.299700e-01 | 0.638 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.736754e-01 | 0.563 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.564018e-01 | 0.591 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.689756e-01 | 0.772 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.047636e-01 | 0.689 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.285593e-01 | 0.641 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.931620e-01 | 0.533 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.157366e-01 | 0.666 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.639129e-01 | 0.785 | 1 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.639129e-01 | 0.785 | 1 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.915647e-01 | 0.718 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.499600e-01 | 0.602 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.893586e-01 | 0.539 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.281920e-01 | 0.642 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.281920e-01 | 0.642 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.635332e-01 | 0.579 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.339242e-01 | 0.631 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.339242e-01 | 0.631 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.680647e-01 | 0.775 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.789118e-01 | 0.555 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.930520e-01 | 0.714 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.490651e-01 | 0.604 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.695803e-01 | 0.771 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.704877e-01 | 0.568 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.488061e-01 | 0.604 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.943987e-01 | 0.711 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.399758e-01 | 0.620 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.377630e-01 | 0.624 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.789118e-01 | 0.555 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.478030e-01 | 0.606 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.308357e-01 | 0.637 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.852437e-01 | 0.545 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.714001e-01 | 0.566 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 2.635332e-01 | 0.579 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 1.830781e-01 | 0.737 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.237066e-01 | 0.490 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.181133e-01 | 0.661 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.181133e-01 | 0.661 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.984297e-01 | 0.702 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.911151e-01 | 0.719 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.237066e-01 | 0.490 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.635332e-01 | 0.579 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.676794e-01 | 0.776 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.894514e-01 | 0.723 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.789118e-01 | 0.555 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.974576e-01 | 0.527 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.689756e-01 | 0.772 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.140748e-01 | 0.669 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.309581e-01 | 0.636 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.839248e-01 | 0.547 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.974576e-01 | 0.527 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.676794e-01 | 0.776 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.676794e-01 | 0.776 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.339242e-01 | 0.631 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.054706e-01 | 0.687 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 3.119453e-01 | 0.506 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.225365e-01 | 0.491 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.158880e-01 | 0.500 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.600587e-01 | 0.585 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 3.013711e-01 | 0.521 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.115723e-01 | 0.675 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 2.789118e-01 | 0.555 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.157366e-01 | 0.666 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.564018e-01 | 0.591 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.644327e-01 | 0.784 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.596478e-01 | 0.586 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.676794e-01 | 0.776 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.069008e-01 | 0.513 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.789118e-01 | 0.555 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 2.789118e-01 | 0.555 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.738549e-01 | 0.760 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 3.013711e-01 | 0.521 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.110662e-01 | 0.507 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.013711e-01 | 0.521 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.439832e-01 | 0.613 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.247310e-01 | 0.488 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.247310e-01 | 0.488 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.283543e-01 | 0.484 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.283543e-01 | 0.484 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.283543e-01 | 0.484 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.283543e-01 | 0.484 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.336182e-01 | 0.477 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.339359e-01 | 0.476 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.404137e-01 | 0.468 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.449174e-01 | 0.462 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.458540e-01 | 0.461 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.458540e-01 | 0.461 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 3.458540e-01 | 0.461 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.458540e-01 | 0.461 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.458540e-01 | 0.461 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.458540e-01 | 0.461 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.483673e-01 | 0.458 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.483673e-01 | 0.458 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 3.483673e-01 | 0.458 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 3.483673e-01 | 0.458 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 3.483673e-01 | 0.458 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.483673e-01 | 0.458 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 3.483673e-01 | 0.458 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.483673e-01 | 0.458 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.483673e-01 | 0.458 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.483673e-01 | 0.458 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.483673e-01 | 0.458 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.483673e-01 | 0.458 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.521548e-01 | 0.453 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.607744e-01 | 0.443 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.614429e-01 | 0.442 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.614429e-01 | 0.442 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.658780e-01 | 0.437 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.658780e-01 | 0.437 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.658780e-01 | 0.437 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.664582e-01 | 0.436 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 3.677570e-01 | 0.434 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.677570e-01 | 0.434 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.677570e-01 | 0.434 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 3.677570e-01 | 0.434 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 3.677570e-01 | 0.434 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 3.677570e-01 | 0.434 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.698798e-01 | 0.432 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.779029e-01 | 0.423 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.779029e-01 | 0.423 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.779029e-01 | 0.423 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.779029e-01 | 0.423 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.779029e-01 | 0.423 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 3.779029e-01 | 0.423 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.795860e-01 | 0.421 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.847752e-01 | 0.415 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.868247e-01 | 0.412 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.870497e-01 | 0.412 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.870497e-01 | 0.412 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.870497e-01 | 0.412 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.870497e-01 | 0.412 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.870497e-01 | 0.412 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.870497e-01 | 0.412 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.870497e-01 | 0.412 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.870497e-01 | 0.412 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.870497e-01 | 0.412 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.870497e-01 | 0.412 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.870497e-01 | 0.412 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.870497e-01 | 0.412 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 3.870497e-01 | 0.412 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.870497e-01 | 0.412 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.893666e-01 | 0.410 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.893666e-01 | 0.410 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 3.893666e-01 | 0.410 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.921467e-01 | 0.407 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.932627e-01 | 0.405 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.942718e-01 | 0.404 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.942718e-01 | 0.404 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.942718e-01 | 0.404 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.942718e-01 | 0.404 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 3.975830e-01 | 0.401 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.066685e-01 | 0.391 | 1 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.068927e-01 | 0.391 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.068927e-01 | 0.391 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.087031e-01 | 0.389 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.105255e-01 | 0.387 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.106406e-01 | 0.387 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 4.106406e-01 | 0.387 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.106406e-01 | 0.387 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.106406e-01 | 0.387 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.106406e-01 | 0.387 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.106406e-01 | 0.387 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 4.106406e-01 | 0.387 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 4.106406e-01 | 0.387 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.106406e-01 | 0.387 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 4.106406e-01 | 0.387 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.106406e-01 | 0.387 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.142761e-01 | 0.383 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.142761e-01 | 0.383 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.190639e-01 | 0.378 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.204613e-01 | 0.376 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.204613e-01 | 0.376 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.223593e-01 | 0.374 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 4.234380e-01 | 0.373 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 4.234380e-01 | 0.373 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 4.234380e-01 | 0.373 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 4.234380e-01 | 0.373 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.234380e-01 | 0.373 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.234380e-01 | 0.373 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 4.234380e-01 | 0.373 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.261627e-01 | 0.370 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.266418e-01 | 0.370 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.266418e-01 | 0.370 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.266418e-01 | 0.370 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.266418e-01 | 0.370 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.266418e-01 | 0.370 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.266418e-01 | 0.370 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.276958e-01 | 0.369 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.315426e-01 | 0.365 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.315426e-01 | 0.365 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 4.315426e-01 | 0.365 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.338378e-01 | 0.363 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.339546e-01 | 0.363 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 4.404466e-01 | 0.356 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.426002e-01 | 0.354 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.426002e-01 | 0.354 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.426002e-01 | 0.354 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.426002e-01 | 0.354 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 4.426002e-01 | 0.354 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.435364e-01 | 0.353 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.436923e-01 | 0.353 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.516705e-01 | 0.345 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 4.517520e-01 | 0.345 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 4.520419e-01 | 0.345 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.520419e-01 | 0.345 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.520419e-01 | 0.345 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.576682e-01 | 0.339 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.576682e-01 | 0.339 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.576682e-01 | 0.339 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.576682e-01 | 0.339 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 4.576682e-01 | 0.339 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 4.576682e-01 | 0.339 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.576682e-01 | 0.339 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 4.576682e-01 | 0.339 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.606633e-01 | 0.337 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.606633e-01 | 0.337 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.606633e-01 | 0.337 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.669725e-01 | 0.331 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.669725e-01 | 0.331 | 1 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.687141e-01 | 0.329 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 4.721127e-01 | 0.326 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.721127e-01 | 0.326 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 4.721127e-01 | 0.326 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.721127e-01 | 0.326 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.721127e-01 | 0.326 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.721127e-01 | 0.326 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.739702e-01 | 0.324 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.808440e-01 | 0.318 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.808440e-01 | 0.318 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.840118e-01 | 0.315 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.840118e-01 | 0.315 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.869222e-01 | 0.313 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.893491e-01 | 0.310 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.893491e-01 | 0.310 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.893491e-01 | 0.310 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.893491e-01 | 0.310 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.893491e-01 | 0.310 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.898681e-01 | 0.310 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.898681e-01 | 0.310 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.898681e-01 | 0.310 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.898681e-01 | 0.310 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.898681e-01 | 0.310 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.898681e-01 | 0.310 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.898681e-01 | 0.310 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.898681e-01 | 0.310 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.898681e-01 | 0.310 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.898681e-01 | 0.310 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.898681e-01 | 0.310 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.898681e-01 | 0.310 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.898681e-01 | 0.310 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.898681e-01 | 0.310 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.898681e-01 | 0.310 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.898681e-01 | 0.310 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.904504e-01 | 0.309 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.919710e-01 | 0.308 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.919710e-01 | 0.308 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.919710e-01 | 0.308 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.950052e-01 | 0.305 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.998560e-01 | 0.301 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.998560e-01 | 0.301 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.027229e-01 | 0.299 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.034517e-01 | 0.298 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.034517e-01 | 0.298 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.043191e-01 | 0.297 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.045046e-01 | 0.297 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.045046e-01 | 0.297 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.094015e-01 | 0.293 | 0 | 0 |
| Free fatty acid receptors | R-HSA-444209 | 5.108874e-01 | 0.292 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.108874e-01 | 0.292 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.108874e-01 | 0.292 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 5.108874e-01 | 0.292 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 5.108874e-01 | 0.292 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.126465e-01 | 0.290 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.137201e-01 | 0.289 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.201580e-01 | 0.284 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 5.201580e-01 | 0.284 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.201580e-01 | 0.284 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.201580e-01 | 0.284 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 5.201580e-01 | 0.284 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.201580e-01 | 0.284 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 5.201580e-01 | 0.284 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 5.201580e-01 | 0.284 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 5.201580e-01 | 0.284 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.201580e-01 | 0.284 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.201580e-01 | 0.284 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.201580e-01 | 0.284 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.201580e-01 | 0.284 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.201580e-01 | 0.284 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.201580e-01 | 0.284 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.201580e-01 | 0.284 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.201580e-01 | 0.284 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 5.201580e-01 | 0.284 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.239071e-01 | 0.281 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.244242e-01 | 0.280 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.252848e-01 | 0.280 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.295603e-01 | 0.276 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.295603e-01 | 0.276 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.295603e-01 | 0.276 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.299807e-01 | 0.276 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.299807e-01 | 0.276 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.299807e-01 | 0.276 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.299807e-01 | 0.276 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.340966e-01 | 0.272 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.340966e-01 | 0.272 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.340966e-01 | 0.272 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.375905e-01 | 0.270 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.375905e-01 | 0.270 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.410230e-01 | 0.267 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.477419e-01 | 0.261 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.477419e-01 | 0.261 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 5.477419e-01 | 0.261 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.477419e-01 | 0.261 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.477419e-01 | 0.261 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.477419e-01 | 0.261 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.485120e-01 | 0.261 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.485120e-01 | 0.261 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.485120e-01 | 0.261 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.486511e-01 | 0.261 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.486511e-01 | 0.261 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 5.486511e-01 | 0.261 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.486511e-01 | 0.261 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 5.486511e-01 | 0.261 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.486511e-01 | 0.261 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.486511e-01 | 0.261 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.486511e-01 | 0.261 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.486511e-01 | 0.261 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.486511e-01 | 0.261 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.486511e-01 | 0.261 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 5.486511e-01 | 0.261 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.486511e-01 | 0.261 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.494436e-01 | 0.260 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.494436e-01 | 0.260 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.500730e-01 | 0.260 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.500730e-01 | 0.260 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.518626e-01 | 0.258 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.519429e-01 | 0.258 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.622086e-01 | 0.250 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.626617e-01 | 0.250 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.626617e-01 | 0.250 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.627346e-01 | 0.250 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.627346e-01 | 0.250 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.650121e-01 | 0.248 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.650121e-01 | 0.248 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.654247e-01 | 0.248 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.654247e-01 | 0.248 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.694600e-01 | 0.245 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.754539e-01 | 0.240 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 5.754539e-01 | 0.240 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 5.754539e-01 | 0.240 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 5.754539e-01 | 0.240 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.754539e-01 | 0.240 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.754539e-01 | 0.240 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.754539e-01 | 0.240 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 5.754539e-01 | 0.240 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 5.754539e-01 | 0.240 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.754539e-01 | 0.240 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 5.754539e-01 | 0.240 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.754539e-01 | 0.240 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.754539e-01 | 0.240 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 5.754539e-01 | 0.240 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.765383e-01 | 0.239 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 5.765383e-01 | 0.239 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.826038e-01 | 0.235 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.826038e-01 | 0.235 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.826038e-01 | 0.235 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.839151e-01 | 0.234 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.859318e-01 | 0.232 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.859318e-01 | 0.232 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 5.901353e-01 | 0.229 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.901353e-01 | 0.229 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 5.901353e-01 | 0.229 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.901353e-01 | 0.229 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.914149e-01 | 0.228 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.925444e-01 | 0.227 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.942950e-01 | 0.226 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.991115e-01 | 0.222 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.992768e-01 | 0.222 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.992768e-01 | 0.222 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.992768e-01 | 0.222 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.992768e-01 | 0.222 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.992768e-01 | 0.222 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 5.992768e-01 | 0.222 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 5.992768e-01 | 0.222 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.001041e-01 | 0.222 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.006666e-01 | 0.221 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.006666e-01 | 0.221 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 6.006666e-01 | 0.221 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.006666e-01 | 0.221 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.006666e-01 | 0.221 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.006666e-01 | 0.221 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.006666e-01 | 0.221 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.019196e-01 | 0.220 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.034475e-01 | 0.219 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.045293e-01 | 0.219 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.075764e-01 | 0.216 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.088900e-01 | 0.215 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.146146e-01 | 0.211 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.154431e-01 | 0.211 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.154431e-01 | 0.211 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.164707e-01 | 0.210 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.200716e-01 | 0.208 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 6.200716e-01 | 0.208 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.200716e-01 | 0.208 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.243833e-01 | 0.205 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.243833e-01 | 0.205 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 6.243833e-01 | 0.205 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 6.243833e-01 | 0.205 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 6.243833e-01 | 0.205 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.243833e-01 | 0.205 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 6.243833e-01 | 0.205 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.243833e-01 | 0.205 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 6.243833e-01 | 0.205 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.243833e-01 | 0.205 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.243833e-01 | 0.205 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.243833e-01 | 0.205 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 6.243833e-01 | 0.205 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 6.243833e-01 | 0.205 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.245476e-01 | 0.204 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.276466e-01 | 0.202 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.292013e-01 | 0.201 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.292013e-01 | 0.201 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.292013e-01 | 0.201 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.292013e-01 | 0.201 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.292013e-01 | 0.201 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.300812e-01 | 0.201 | 1 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.310500e-01 | 0.200 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 6.311041e-01 | 0.200 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.416370e-01 | 0.193 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.416370e-01 | 0.193 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.437405e-01 | 0.191 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.439459e-01 | 0.191 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 6.462627e-01 | 0.190 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.462627e-01 | 0.190 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.462627e-01 | 0.190 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.462627e-01 | 0.190 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.466929e-01 | 0.189 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 6.466929e-01 | 0.189 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.466929e-01 | 0.189 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 6.466929e-01 | 0.189 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 6.466929e-01 | 0.189 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 6.466929e-01 | 0.189 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 6.466929e-01 | 0.189 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.609235e-01 | 0.180 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.609235e-01 | 0.180 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.609235e-01 | 0.180 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.656173e-01 | 0.177 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.656173e-01 | 0.177 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 6.676787e-01 | 0.175 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.676787e-01 | 0.175 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.676787e-01 | 0.175 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 6.676787e-01 | 0.175 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.676787e-01 | 0.175 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.676787e-01 | 0.175 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 6.676787e-01 | 0.175 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.676787e-01 | 0.175 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 6.676787e-01 | 0.175 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 6.676787e-01 | 0.175 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 6.676787e-01 | 0.175 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.676787e-01 | 0.175 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.676787e-01 | 0.175 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 6.676787e-01 | 0.175 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 6.676787e-01 | 0.175 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.676787e-01 | 0.175 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.676787e-01 | 0.175 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 6.676787e-01 | 0.175 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.676787e-01 | 0.175 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.676787e-01 | 0.175 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.720405e-01 | 0.173 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.724849e-01 | 0.172 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 6.750920e-01 | 0.171 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.806509e-01 | 0.167 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.808110e-01 | 0.167 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.874191e-01 | 0.163 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.874191e-01 | 0.163 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 6.874191e-01 | 0.163 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.874191e-01 | 0.163 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.874191e-01 | 0.163 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 6.874191e-01 | 0.163 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.874191e-01 | 0.163 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.874191e-01 | 0.163 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.874191e-01 | 0.163 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.874191e-01 | 0.163 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.874191e-01 | 0.163 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.884067e-01 | 0.162 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.884067e-01 | 0.162 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.887750e-01 | 0.162 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.993562e-01 | 0.155 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.019802e-01 | 0.154 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.019802e-01 | 0.154 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.059881e-01 | 0.151 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.059881e-01 | 0.151 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 7.059881e-01 | 0.151 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 7.059881e-01 | 0.151 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.059881e-01 | 0.151 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.059881e-01 | 0.151 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.059881e-01 | 0.151 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.113196e-01 | 0.148 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.147160e-01 | 0.146 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.147160e-01 | 0.146 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.147160e-01 | 0.146 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 7.147160e-01 | 0.146 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.147160e-01 | 0.146 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.203725e-01 | 0.142 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.203947e-01 | 0.142 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.203947e-01 | 0.142 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.234550e-01 | 0.141 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.234550e-01 | 0.141 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.234550e-01 | 0.141 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.234550e-01 | 0.141 | 1 | 1 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 7.234550e-01 | 0.141 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 7.234550e-01 | 0.141 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.234550e-01 | 0.141 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.234550e-01 | 0.141 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 7.234550e-01 | 0.141 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.234550e-01 | 0.141 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.245205e-01 | 0.140 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.301787e-01 | 0.137 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.304438e-01 | 0.136 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.311307e-01 | 0.136 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.319415e-01 | 0.136 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.345000e-01 | 0.134 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.388166e-01 | 0.131 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.388166e-01 | 0.131 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.388166e-01 | 0.131 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.398852e-01 | 0.131 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.398852e-01 | 0.131 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.398852e-01 | 0.131 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.398852e-01 | 0.131 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.398852e-01 | 0.131 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.416324e-01 | 0.130 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.421380e-01 | 0.130 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.432439e-01 | 0.129 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.463475e-01 | 0.127 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.463475e-01 | 0.127 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.465642e-01 | 0.127 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.497273e-01 | 0.125 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.497273e-01 | 0.125 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.497273e-01 | 0.125 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.502013e-01 | 0.125 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.553401e-01 | 0.122 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.553401e-01 | 0.122 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 7.553401e-01 | 0.122 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.553401e-01 | 0.122 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 7.553401e-01 | 0.122 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.553401e-01 | 0.122 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 7.553401e-01 | 0.122 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.554825e-01 | 0.122 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.589465e-01 | 0.120 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.611562e-01 | 0.119 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.611562e-01 | 0.119 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.678891e-01 | 0.115 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.678891e-01 | 0.115 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.687823e-01 | 0.114 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.687823e-01 | 0.114 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.687823e-01 | 0.114 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.687823e-01 | 0.114 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.698777e-01 | 0.114 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.698777e-01 | 0.114 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.698777e-01 | 0.114 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.698777e-01 | 0.114 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.698777e-01 | 0.114 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 7.716922e-01 | 0.113 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.716922e-01 | 0.113 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.716922e-01 | 0.113 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.765594e-01 | 0.110 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.765594e-01 | 0.110 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.765594e-01 | 0.110 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.818204e-01 | 0.107 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.818204e-01 | 0.107 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.818204e-01 | 0.107 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.818204e-01 | 0.107 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.818204e-01 | 0.107 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.818204e-01 | 0.107 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.818204e-01 | 0.107 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 7.835523e-01 | 0.106 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.835523e-01 | 0.106 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.835523e-01 | 0.106 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.835523e-01 | 0.106 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 7.835523e-01 | 0.106 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.835523e-01 | 0.106 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.849617e-01 | 0.105 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.849617e-01 | 0.105 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.854475e-01 | 0.105 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.894202e-01 | 0.103 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.915520e-01 | 0.102 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.915520e-01 | 0.102 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.915520e-01 | 0.102 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.931009e-01 | 0.101 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.931009e-01 | 0.101 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.953966e-01 | 0.099 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 7.964151e-01 | 0.099 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 7.964151e-01 | 0.099 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.964151e-01 | 0.099 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 7.964151e-01 | 0.099 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 7.964151e-01 | 0.099 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.964151e-01 | 0.099 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.964151e-01 | 0.099 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.008984e-01 | 0.096 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.008984e-01 | 0.096 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.008984e-01 | 0.096 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.008984e-01 | 0.096 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.008984e-01 | 0.096 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.009817e-01 | 0.096 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.085142e-01 | 0.092 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.085142e-01 | 0.092 | 0 | 0 |
| Eicosanoids | R-HSA-211979 | 8.085142e-01 | 0.092 | 0 | 0 |
| Miscellaneous substrates | R-HSA-211958 | 8.085142e-01 | 0.092 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.085142e-01 | 0.092 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.085142e-01 | 0.092 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.086092e-01 | 0.092 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.098709e-01 | 0.092 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.131413e-01 | 0.090 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.184810e-01 | 0.087 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.184810e-01 | 0.087 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.198196e-01 | 0.086 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.198950e-01 | 0.086 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.198950e-01 | 0.086 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.198950e-01 | 0.086 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.198950e-01 | 0.086 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.198950e-01 | 0.086 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 8.198950e-01 | 0.086 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.198950e-01 | 0.086 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.198950e-01 | 0.086 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.198950e-01 | 0.086 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.198950e-01 | 0.086 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.221785e-01 | 0.085 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.267401e-01 | 0.083 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.267401e-01 | 0.083 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.291668e-01 | 0.081 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.306000e-01 | 0.081 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.306000e-01 | 0.081 | 0 | 0 |
| Fatty acids | R-HSA-211935 | 8.306000e-01 | 0.081 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.306000e-01 | 0.081 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.306000e-01 | 0.081 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.306000e-01 | 0.081 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.306000e-01 | 0.081 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.311002e-01 | 0.080 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.346594e-01 | 0.078 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.346594e-01 | 0.078 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.406693e-01 | 0.075 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.406693e-01 | 0.075 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.406693e-01 | 0.075 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.418127e-01 | 0.075 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.422501e-01 | 0.075 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.491247e-01 | 0.071 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.501406e-01 | 0.071 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.501406e-01 | 0.071 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.501406e-01 | 0.071 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.501406e-01 | 0.071 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.501406e-01 | 0.071 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.501406e-01 | 0.071 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.501406e-01 | 0.071 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.545146e-01 | 0.068 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.545146e-01 | 0.068 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.564898e-01 | 0.067 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.568272e-01 | 0.067 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.568272e-01 | 0.067 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.590495e-01 | 0.066 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.590495e-01 | 0.066 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 8.590495e-01 | 0.066 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.590495e-01 | 0.066 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.648045e-01 | 0.063 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.660184e-01 | 0.062 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.667324e-01 | 0.062 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.667324e-01 | 0.062 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.674293e-01 | 0.062 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.674293e-01 | 0.062 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.674293e-01 | 0.062 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.674293e-01 | 0.062 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.674293e-01 | 0.062 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.674293e-01 | 0.062 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.753113e-01 | 0.058 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.753113e-01 | 0.058 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.753113e-01 | 0.058 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.753113e-01 | 0.058 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.753113e-01 | 0.058 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.791980e-01 | 0.056 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.815018e-01 | 0.055 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.815018e-01 | 0.055 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.823239e-01 | 0.054 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.827252e-01 | 0.054 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.827252e-01 | 0.054 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.827252e-01 | 0.054 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 8.827252e-01 | 0.054 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.827252e-01 | 0.054 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.827252e-01 | 0.054 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.870923e-01 | 0.052 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.870923e-01 | 0.052 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.870923e-01 | 0.052 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.870923e-01 | 0.052 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.871481e-01 | 0.052 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.872751e-01 | 0.052 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.878337e-01 | 0.052 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.896987e-01 | 0.051 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.896987e-01 | 0.051 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.962579e-01 | 0.048 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.962579e-01 | 0.048 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 8.962579e-01 | 0.048 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 8.962694e-01 | 0.048 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.975466e-01 | 0.047 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.975466e-01 | 0.047 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.985194e-01 | 0.046 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.985194e-01 | 0.046 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.000960e-01 | 0.046 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.000960e-01 | 0.046 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.020452e-01 | 0.045 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.024274e-01 | 0.045 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.024274e-01 | 0.045 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.024290e-01 | 0.045 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 9.082304e-01 | 0.042 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.082304e-01 | 0.042 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.087109e-01 | 0.042 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.108836e-01 | 0.041 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.115485e-01 | 0.040 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.115485e-01 | 0.040 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.136885e-01 | 0.039 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.136885e-01 | 0.039 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.136885e-01 | 0.039 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.136885e-01 | 0.039 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.158028e-01 | 0.038 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.161278e-01 | 0.038 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.188224e-01 | 0.037 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.188224e-01 | 0.037 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.188224e-01 | 0.037 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.188224e-01 | 0.037 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.198642e-01 | 0.036 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.198642e-01 | 0.036 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.207474e-01 | 0.036 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.236512e-01 | 0.034 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.236512e-01 | 0.034 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.236512e-01 | 0.034 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.236512e-01 | 0.034 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 9.236512e-01 | 0.034 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.237408e-01 | 0.034 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.238111e-01 | 0.034 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.274401e-01 | 0.033 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.279367e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.281930e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.281930e-01 | 0.032 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.281930e-01 | 0.032 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.281930e-01 | 0.032 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.303833e-01 | 0.031 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.324649e-01 | 0.030 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 9.324649e-01 | 0.030 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.324649e-01 | 0.030 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.324649e-01 | 0.030 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.324649e-01 | 0.030 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.326406e-01 | 0.030 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.345652e-01 | 0.029 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.355439e-01 | 0.029 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.364829e-01 | 0.029 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.364829e-01 | 0.029 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.364829e-01 | 0.029 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.364829e-01 | 0.029 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.375465e-01 | 0.028 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.402621e-01 | 0.027 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.406078e-01 | 0.027 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.427150e-01 | 0.026 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.435261e-01 | 0.025 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.435745e-01 | 0.025 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.438166e-01 | 0.025 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.438166e-01 | 0.025 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.438166e-01 | 0.025 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.463077e-01 | 0.024 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.463077e-01 | 0.024 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.471598e-01 | 0.024 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.471598e-01 | 0.024 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.471598e-01 | 0.024 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.471598e-01 | 0.024 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.474522e-01 | 0.023 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.484015e-01 | 0.023 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.503043e-01 | 0.022 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.503043e-01 | 0.022 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.503043e-01 | 0.022 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.503043e-01 | 0.022 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.503043e-01 | 0.022 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.503043e-01 | 0.022 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.506682e-01 | 0.022 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.514841e-01 | 0.022 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.538902e-01 | 0.021 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.549256e-01 | 0.020 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.560435e-01 | 0.020 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.561123e-01 | 0.019 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.569230e-01 | 0.019 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.583643e-01 | 0.018 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.586598e-01 | 0.018 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.586598e-01 | 0.018 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.586598e-01 | 0.018 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.599059e-01 | 0.018 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.604424e-01 | 0.018 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.604424e-01 | 0.018 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.604424e-01 | 0.018 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.611205e-01 | 0.017 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.611205e-01 | 0.017 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.611205e-01 | 0.017 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.612186e-01 | 0.017 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.624207e-01 | 0.017 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.634349e-01 | 0.016 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.634349e-01 | 0.016 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.634349e-01 | 0.016 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.656117e-01 | 0.015 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.656117e-01 | 0.015 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.656117e-01 | 0.015 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.660705e-01 | 0.015 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.676590e-01 | 0.014 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.678018e-01 | 0.014 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.678018e-01 | 0.014 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.687458e-01 | 0.014 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.692733e-01 | 0.014 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.694246e-01 | 0.013 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.695845e-01 | 0.013 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.701604e-01 | 0.013 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.713955e-01 | 0.013 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.730987e-01 | 0.012 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.730987e-01 | 0.012 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.739201e-01 | 0.011 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.747007e-01 | 0.011 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.747007e-01 | 0.011 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.747007e-01 | 0.011 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.747007e-01 | 0.011 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.751619e-01 | 0.011 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.762073e-01 | 0.010 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.763696e-01 | 0.010 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.776243e-01 | 0.010 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.784916e-01 | 0.009 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.789570e-01 | 0.009 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.798519e-01 | 0.009 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.802104e-01 | 0.009 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.834556e-01 | 0.007 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.835405e-01 | 0.007 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.836784e-01 | 0.007 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.845211e-01 | 0.007 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.845766e-01 | 0.007 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.852981e-01 | 0.006 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.854434e-01 | 0.006 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.854434e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.860749e-01 | 0.006 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.866712e-01 | 0.006 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.874785e-01 | 0.005 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.878936e-01 | 0.005 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.886694e-01 | 0.005 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.887439e-01 | 0.005 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.893289e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.899318e-01 | 0.004 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.899318e-01 | 0.004 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.904215e-01 | 0.004 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.904865e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.916271e-01 | 0.004 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.916271e-01 | 0.004 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.916271e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.917843e-01 | 0.004 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.921263e-01 | 0.003 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.921263e-01 | 0.003 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.938428e-01 | 0.003 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.942896e-01 | 0.002 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.943228e-01 | 0.002 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.944048e-01 | 0.002 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.944170e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.948800e-01 | 0.002 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.949826e-01 | 0.002 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.954970e-01 | 0.002 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.957427e-01 | 0.002 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.958947e-01 | 0.002 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.962355e-01 | 0.002 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.964601e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.967542e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.969594e-01 | 0.001 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.970567e-01 | 0.001 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.970567e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.976647e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.976990e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.978710e-01 | 0.001 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.981731e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.982012e-01 | 0.001 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.983420e-01 | 0.001 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.984096e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.985938e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.987568e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.988310e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.990213e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.990863e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.991922e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.992596e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.992694e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.993093e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.994064e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.994419e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.995083e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.995602e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.995913e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.996681e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.997787e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.997787e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.998044e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.998122e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.998243e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.998461e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.998581e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.998806e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998878e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998982e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999271e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999284e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999547e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999556e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999569e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999664e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999665e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999775e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999872e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999933e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999961e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999964e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999966e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999979e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999980e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.110223e-16 | 15.955 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.440892e-16 | 15.353 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.221245e-15 | 14.913 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.998401e-15 | 14.699 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.998401e-15 | 14.699 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.773959e-15 | 14.321 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.884182e-15 | 14.230 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.296563e-14 | 13.367 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.584422e-14 | 13.253 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.673240e-14 | 13.246 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.673240e-14 | 13.246 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.217249e-14 | 13.206 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.137935e-14 | 13.089 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.114931e-14 | 13.040 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.548761e-13 | 12.810 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.599831e-13 | 12.796 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.966205e-13 | 12.706 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.661205e-13 | 12.575 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.774447e-13 | 12.557 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.017897e-13 | 12.396 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.215517e-13 | 12.375 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.340173e-13 | 12.272 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.252776e-13 | 12.204 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.782663e-13 | 12.109 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.187717e-12 | 11.925 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.373790e-12 | 11.862 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.546763e-12 | 11.811 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.927769e-12 | 11.533 | 1 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.419798e-12 | 11.355 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.707013e-12 | 11.327 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.655720e-12 | 11.332 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.946377e-12 | 11.306 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.673329e-12 | 11.176 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.117862e-12 | 11.148 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.275514e-12 | 11.138 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.659407e-12 | 11.063 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.249490e-12 | 11.034 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.391155e-12 | 11.027 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.497047e-11 | 10.825 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.523837e-11 | 10.453 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.873491e-11 | 10.163 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.066038e-10 | 9.972 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.062550e-10 | 9.974 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.597856e-10 | 9.796 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.776361e-10 | 9.750 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.003103e-10 | 9.698 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.866588e-10 | 9.543 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.072201e-10 | 9.513 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.136004e-10 | 9.504 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.425027e-10 | 9.465 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.684765e-10 | 9.434 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.256251e-10 | 9.279 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.823588e-10 | 9.235 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.459967e-10 | 9.127 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.876625e-10 | 9.005 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.059224e-09 | 8.975 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.061658e-09 | 8.974 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.238186e-09 | 8.907 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.280118e-09 | 8.893 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.280118e-09 | 8.893 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.273713e-09 | 8.895 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.464622e-09 | 8.834 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.664801e-09 | 8.779 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.679472e-09 | 8.775 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.878617e-09 | 8.726 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.959019e-09 | 8.708 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.232220e-09 | 8.651 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.232220e-09 | 8.651 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.204685e-09 | 8.657 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.363629e-09 | 8.626 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.393020e-09 | 8.621 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.284983e-09 | 8.483 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.459615e-09 | 8.461 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.575581e-09 | 8.447 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.740696e-09 | 8.427 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.108243e-09 | 8.386 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.899786e-09 | 8.229 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.052811e-09 | 8.218 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.052811e-09 | 8.218 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.503419e-09 | 8.187 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.922019e-09 | 8.160 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.509823e-09 | 8.124 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.600599e-09 | 8.065 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 9.356560e-09 | 8.029 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 9.356560e-09 | 8.029 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.029865e-08 | 7.987 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.070152e-08 | 7.971 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.539586e-08 | 7.813 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.573728e-08 | 7.803 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.917550e-08 | 7.717 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.023982e-08 | 7.694 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.103229e-08 | 7.677 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.236039e-08 | 7.651 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.455719e-08 | 7.610 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.586398e-08 | 7.445 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.884358e-08 | 7.311 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.948283e-08 | 7.306 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.259824e-08 | 7.279 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.638444e-08 | 7.249 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.077077e-08 | 7.216 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.737707e-08 | 7.171 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.737707e-08 | 7.171 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.796045e-08 | 7.168 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.659460e-08 | 7.116 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.922205e-08 | 7.101 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.058642e-08 | 7.094 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.722231e-08 | 7.012 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.785626e-08 | 7.009 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.993521e-08 | 7.000 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.993521e-08 | 7.000 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.138332e-07 | 6.944 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.286933e-07 | 6.890 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.408253e-07 | 6.851 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.529374e-07 | 6.815 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.529374e-07 | 6.815 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.819545e-07 | 6.740 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.975611e-07 | 6.704 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.089917e-07 | 6.680 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.198047e-07 | 6.658 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.158198e-07 | 6.666 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.312265e-07 | 6.636 | 1 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.484589e-07 | 6.605 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.689958e-07 | 6.570 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.868333e-07 | 6.542 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.035108e-07 | 6.518 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.377107e-07 | 6.471 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.801799e-07 | 6.420 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.443439e-07 | 6.352 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.579997e-07 | 6.339 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.259782e-07 | 6.279 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.504938e-07 | 6.259 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.578362e-07 | 6.253 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.696196e-07 | 6.244 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.045054e-07 | 6.219 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.034609e-07 | 6.153 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.041221e-07 | 6.095 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 8.276608e-07 | 6.082 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.153039e-07 | 6.038 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.010662e-06 | 5.995 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.015287e-06 | 5.993 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.074209e-06 | 5.969 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.115023e-06 | 5.953 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.231097e-06 | 5.910 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.194547e-06 | 5.923 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.419707e-06 | 5.848 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.424377e-06 | 5.846 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.627760e-06 | 5.788 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.632874e-06 | 5.787 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.729500e-06 | 5.762 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.961040e-06 | 5.708 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.986897e-06 | 5.702 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.990802e-06 | 5.701 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.064743e-06 | 5.685 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.138463e-06 | 5.670 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.175826e-06 | 5.662 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.516526e-06 | 5.599 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.513146e-06 | 5.600 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.513146e-06 | 5.600 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.513146e-06 | 5.600 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.513146e-06 | 5.600 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.660448e-06 | 5.575 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.722827e-06 | 5.429 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.820374e-06 | 5.418 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.497979e-06 | 5.347 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.528359e-06 | 5.344 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.680490e-06 | 5.330 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.853698e-06 | 5.233 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.506030e-06 | 5.187 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.535963e-06 | 5.185 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.846341e-06 | 5.165 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.619583e-06 | 5.118 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.254166e-06 | 5.083 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.333594e-06 | 5.079 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.773135e-06 | 5.057 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.475896e-06 | 5.023 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.004429e-05 | 4.998 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.018830e-05 | 4.992 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.019369e-05 | 4.992 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.032779e-05 | 4.986 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.038605e-05 | 4.984 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.397430e-05 | 4.855 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.415024e-05 | 4.849 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.440302e-05 | 4.842 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.483600e-05 | 4.829 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.529795e-05 | 4.815 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.558797e-05 | 4.807 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.719231e-05 | 4.765 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.983321e-05 | 4.703 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.445643e-05 | 4.612 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.805895e-05 | 4.552 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.637774e-05 | 4.579 | 0 | 0 |
| Translation | R-HSA-72766 | 2.745105e-05 | 4.561 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.813350e-05 | 4.551 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.926303e-05 | 4.534 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.984758e-05 | 4.525 | 1 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.993069e-05 | 4.524 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.993069e-05 | 4.524 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.106644e-05 | 4.508 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.149123e-05 | 4.502 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.151303e-05 | 4.502 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.179339e-05 | 4.498 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.110323e-05 | 4.386 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.590716e-05 | 4.338 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.723797e-05 | 4.326 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.723797e-05 | 4.326 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.798256e-05 | 4.319 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.001894e-05 | 4.301 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.120839e-05 | 4.291 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.428403e-05 | 4.265 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.543522e-05 | 4.256 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.279457e-05 | 4.202 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.735314e-05 | 4.172 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.340997e-05 | 4.134 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.866453e-05 | 4.163 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.744904e-05 | 4.111 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.094716e-05 | 4.149 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.509036e-05 | 4.124 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.509036e-05 | 4.124 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.820905e-05 | 4.107 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.088409e-05 | 4.042 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 9.470048e-05 | 4.024 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.737384e-05 | 4.012 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.064642e-04 | 3.973 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.077040e-04 | 3.968 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.179178e-04 | 3.928 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.244799e-04 | 3.905 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.263713e-04 | 3.898 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.364620e-04 | 3.865 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.394163e-04 | 3.856 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.407517e-04 | 3.852 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.426289e-04 | 3.846 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.450340e-04 | 3.839 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.488896e-04 | 3.827 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.496214e-04 | 3.825 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.548405e-04 | 3.810 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.587230e-04 | 3.799 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.623720e-04 | 3.789 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.674827e-04 | 3.776 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.737628e-04 | 3.760 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.861780e-04 | 3.730 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.917683e-04 | 3.717 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.952696e-04 | 3.709 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.052200e-04 | 3.688 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.058002e-04 | 3.687 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.202478e-04 | 3.657 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.501936e-04 | 3.602 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.898402e-04 | 3.538 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.898402e-04 | 3.538 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.894651e-04 | 3.538 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.009433e-04 | 3.522 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.712021e-04 | 3.567 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.019591e-04 | 3.520 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.023981e-04 | 3.519 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.217810e-04 | 3.492 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.217810e-04 | 3.492 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.231659e-04 | 3.491 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.320259e-04 | 3.479 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.566898e-04 | 3.448 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.579356e-04 | 3.446 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.644439e-04 | 3.438 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.644439e-04 | 3.438 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.649426e-04 | 3.438 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.778704e-04 | 3.423 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.895030e-04 | 3.409 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.208259e-04 | 3.376 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.287586e-04 | 3.368 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.287586e-04 | 3.368 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.805041e-04 | 3.318 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.842468e-04 | 3.315 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.292163e-04 | 3.276 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.292163e-04 | 3.276 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 5.633840e-04 | 3.249 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.919666e-04 | 3.228 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.120713e-04 | 3.147 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.329432e-04 | 3.135 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.329432e-04 | 3.135 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.663040e-04 | 3.116 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.892047e-04 | 3.103 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.031640e-04 | 3.095 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.054624e-04 | 3.094 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.118933e-04 | 3.091 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.118933e-04 | 3.091 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 9.284174e-04 | 3.032 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.649445e-04 | 3.015 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.090565e-03 | 2.962 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.144377e-03 | 2.941 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.152505e-03 | 2.938 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.159080e-03 | 2.936 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.272126e-03 | 2.895 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.292902e-03 | 2.888 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.339681e-03 | 2.873 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.606941e-03 | 2.794 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.491305e-03 | 2.826 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.491305e-03 | 2.826 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.518789e-03 | 2.819 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.608770e-03 | 2.794 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.597421e-03 | 2.797 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.591035e-03 | 2.798 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.606941e-03 | 2.794 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.505007e-03 | 2.822 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.629407e-03 | 2.788 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.704571e-03 | 2.768 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.827864e-03 | 2.738 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.848287e-03 | 2.733 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.923505e-03 | 2.716 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.923594e-03 | 2.716 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.957593e-03 | 2.708 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.014174e-03 | 2.696 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.024164e-03 | 2.694 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.060974e-03 | 2.686 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.159111e-03 | 2.666 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.189152e-03 | 2.660 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.213293e-03 | 2.655 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.213293e-03 | 2.655 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.246406e-03 | 2.649 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.279052e-03 | 2.642 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.412616e-03 | 2.618 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.423431e-03 | 2.616 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.494494e-03 | 2.603 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.510586e-03 | 2.600 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.613097e-03 | 2.583 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.842477e-03 | 2.546 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.853524e-03 | 2.545 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.950003e-03 | 2.530 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.950003e-03 | 2.530 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.998586e-03 | 2.523 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.031656e-03 | 2.518 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.031656e-03 | 2.518 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.153977e-03 | 2.501 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.161501e-03 | 2.500 | 1 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.226145e-03 | 2.491 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.226145e-03 | 2.491 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.226145e-03 | 2.491 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.226145e-03 | 2.491 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.227496e-03 | 2.491 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.330643e-03 | 2.477 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.330643e-03 | 2.477 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.357876e-03 | 2.474 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.447228e-03 | 2.463 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.581663e-03 | 2.446 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.628725e-03 | 2.440 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.481024e-03 | 2.349 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.559259e-03 | 2.341 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.559259e-03 | 2.341 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.559259e-03 | 2.341 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.559259e-03 | 2.341 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.559259e-03 | 2.341 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.559259e-03 | 2.341 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.559259e-03 | 2.341 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.466491e-03 | 2.350 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.466491e-03 | 2.350 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.466491e-03 | 2.350 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.720161e-03 | 2.429 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.466491e-03 | 2.350 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.353244e-03 | 2.361 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.454055e-03 | 2.351 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.679877e-03 | 2.434 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.481024e-03 | 2.349 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.941131e-03 | 2.404 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.516324e-03 | 2.345 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.339976e-03 | 2.363 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.822646e-03 | 2.418 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.720161e-03 | 2.429 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.636658e-03 | 2.334 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.636658e-03 | 2.334 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.664145e-03 | 2.331 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.666988e-03 | 2.331 | 1 | 1 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.952223e-03 | 2.305 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.287020e-03 | 2.277 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.333772e-03 | 2.273 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.370846e-03 | 2.270 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.487280e-03 | 2.261 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.555639e-03 | 2.255 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.642101e-03 | 2.249 | 1 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.667239e-03 | 2.247 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.667239e-03 | 2.247 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.667239e-03 | 2.247 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.992490e-03 | 2.222 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.056509e-03 | 2.218 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.072298e-03 | 2.217 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.270685e-03 | 2.203 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.324991e-03 | 2.199 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.324991e-03 | 2.199 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.324991e-03 | 2.199 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.324991e-03 | 2.199 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 6.529840e-03 | 2.185 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.529840e-03 | 2.185 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.529840e-03 | 2.185 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.592212e-03 | 2.181 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.592212e-03 | 2.181 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.592212e-03 | 2.181 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.592212e-03 | 2.181 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.592212e-03 | 2.181 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.700751e-03 | 2.174 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.025667e-03 | 2.153 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.180576e-03 | 2.144 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.194614e-03 | 2.143 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.194614e-03 | 2.143 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.194614e-03 | 2.143 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.535736e-03 | 2.123 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 7.535736e-03 | 2.123 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.880400e-03 | 2.103 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.880400e-03 | 2.103 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.880400e-03 | 2.103 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.892855e-03 | 2.103 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.114645e-03 | 2.091 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.114645e-03 | 2.091 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.253316e-03 | 2.083 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.253316e-03 | 2.083 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.419808e-03 | 2.075 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.419808e-03 | 2.075 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.419945e-03 | 2.075 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.646907e-03 | 2.063 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.646907e-03 | 2.063 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.865261e-03 | 2.052 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.865261e-03 | 2.052 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.155876e-03 | 2.038 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 9.174151e-03 | 2.037 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 9.174151e-03 | 2.037 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 9.185335e-03 | 2.037 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 9.185335e-03 | 2.037 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 9.185335e-03 | 2.037 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 9.185335e-03 | 2.037 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 9.185335e-03 | 2.037 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.357763e-03 | 2.029 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.357763e-03 | 2.029 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.458795e-03 | 2.024 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.475619e-03 | 2.023 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 9.475619e-03 | 2.023 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.232163e-02 | 1.909 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.232163e-02 | 1.909 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.232163e-02 | 1.909 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.106673e-02 | 1.956 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.106673e-02 | 1.956 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.106673e-02 | 1.956 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.197308e-02 | 1.922 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.162725e-02 | 1.935 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.162725e-02 | 1.935 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.037202e-02 | 1.984 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.665125e-03 | 2.015 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.117684e-02 | 1.952 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.029721e-02 | 1.987 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.029721e-02 | 1.987 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.179644e-02 | 1.928 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.225554e-02 | 1.912 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.225554e-02 | 1.912 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.028880e-02 | 1.988 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.106673e-02 | 1.956 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.207096e-02 | 1.918 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.253410e-02 | 1.902 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.197308e-02 | 1.922 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.973035e-03 | 2.001 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.104179e-02 | 1.957 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.278258e-02 | 1.893 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.278258e-02 | 1.893 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.037202e-02 | 1.984 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.037202e-02 | 1.984 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.253410e-02 | 1.902 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.222561e-02 | 1.913 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.124869e-02 | 1.949 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.941626e-03 | 2.003 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.253410e-02 | 1.902 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.084764e-02 | 1.965 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.204642e-02 | 1.919 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.607712e-03 | 2.017 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.286690e-02 | 1.891 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.295025e-02 | 1.888 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.336175e-02 | 1.874 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.336175e-02 | 1.874 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.338181e-02 | 1.873 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.346113e-02 | 1.871 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.376859e-02 | 1.861 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.376859e-02 | 1.861 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.376859e-02 | 1.861 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.388845e-02 | 1.857 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.397720e-02 | 1.855 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.426960e-02 | 1.846 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.431700e-02 | 1.844 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.437183e-02 | 1.842 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.445132e-02 | 1.840 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.445132e-02 | 1.840 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.445132e-02 | 1.840 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.445132e-02 | 1.840 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.445132e-02 | 1.840 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.445132e-02 | 1.840 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.445132e-02 | 1.840 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.445132e-02 | 1.840 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.445132e-02 | 1.840 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.445132e-02 | 1.840 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.445132e-02 | 1.840 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.445132e-02 | 1.840 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.445433e-02 | 1.840 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.471079e-02 | 1.832 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.489652e-02 | 1.827 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.489652e-02 | 1.827 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.492339e-02 | 1.826 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.492339e-02 | 1.826 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.492339e-02 | 1.826 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.492339e-02 | 1.826 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.510106e-02 | 1.821 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.530270e-02 | 1.815 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.530270e-02 | 1.815 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.598474e-02 | 1.796 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.610600e-02 | 1.793 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.619524e-02 | 1.791 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.665794e-02 | 1.778 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.665794e-02 | 1.778 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.683446e-02 | 1.774 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.719004e-02 | 1.765 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.719004e-02 | 1.765 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.733265e-02 | 1.761 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.751215e-02 | 1.757 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.779223e-02 | 1.750 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.797396e-02 | 1.745 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.836826e-02 | 1.736 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.847258e-02 | 1.733 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.847258e-02 | 1.733 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.847258e-02 | 1.733 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.867697e-02 | 1.729 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.892848e-02 | 1.723 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.892848e-02 | 1.723 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.892848e-02 | 1.723 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.908351e-02 | 1.719 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.908351e-02 | 1.719 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.014650e-02 | 1.696 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.020128e-02 | 1.695 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.020128e-02 | 1.695 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.020128e-02 | 1.695 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.029015e-02 | 1.693 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.094678e-02 | 1.679 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.109208e-02 | 1.676 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.148944e-02 | 1.668 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.148944e-02 | 1.668 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.158475e-02 | 1.666 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.234753e-02 | 1.651 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.234753e-02 | 1.651 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.234753e-02 | 1.651 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.234753e-02 | 1.651 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.256478e-02 | 1.647 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.256478e-02 | 1.647 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.445116e-02 | 1.612 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.453427e-02 | 1.610 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.522244e-02 | 1.598 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.522244e-02 | 1.598 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.522244e-02 | 1.598 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.539772e-02 | 1.595 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.539772e-02 | 1.595 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.570128e-02 | 1.590 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.625037e-02 | 1.581 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.648305e-02 | 1.577 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.658977e-02 | 1.575 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.676170e-02 | 1.572 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.689850e-02 | 1.570 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.689850e-02 | 1.570 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.752138e-02 | 1.560 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.752138e-02 | 1.560 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.768197e-02 | 1.558 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.768197e-02 | 1.558 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.775776e-02 | 1.557 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.775776e-02 | 1.557 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.776529e-02 | 1.556 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.010906e-02 | 1.521 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.061490e-02 | 1.514 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.061490e-02 | 1.514 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.061490e-02 | 1.514 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.070671e-02 | 1.513 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.845759e-02 | 1.415 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.438273e-02 | 1.464 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.438273e-02 | 1.464 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.438273e-02 | 1.464 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.370621e-02 | 1.472 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.044640e-02 | 1.393 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.784854e-02 | 1.422 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.430447e-02 | 1.354 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.292200e-02 | 1.367 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.447165e-02 | 1.463 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.681431e-02 | 1.434 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.661884e-02 | 1.331 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.288321e-02 | 1.368 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.230475e-02 | 1.374 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.226008e-02 | 1.374 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.050392e-02 | 1.393 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.311189e-02 | 1.365 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.679175e-02 | 1.434 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.572397e-02 | 1.340 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.438273e-02 | 1.464 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.661884e-02 | 1.331 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.290224e-02 | 1.368 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.899794e-02 | 1.409 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.661884e-02 | 1.331 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.776557e-02 | 1.423 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.752957e-02 | 1.323 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.592208e-02 | 1.338 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.681431e-02 | 1.434 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.044640e-02 | 1.393 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.840930e-02 | 1.416 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.437233e-02 | 1.464 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.081581e-02 | 1.389 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.283825e-02 | 1.484 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.776557e-02 | 1.423 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.725887e-02 | 1.326 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.845759e-02 | 1.415 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.840930e-02 | 1.416 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.478524e-02 | 1.349 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.438273e-02 | 1.464 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.478524e-02 | 1.349 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.333507e-02 | 1.477 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.848906e-02 | 1.415 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.292200e-02 | 1.367 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.561672e-02 | 1.341 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.632032e-02 | 1.440 | 1 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.288321e-02 | 1.368 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.226008e-02 | 1.374 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.288321e-02 | 1.368 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.840930e-02 | 1.416 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.770054e-02 | 1.321 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.778951e-02 | 1.321 | 1 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.830007e-02 | 1.316 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.859416e-02 | 1.313 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.118571e-02 | 1.291 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.118571e-02 | 1.291 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.119444e-02 | 1.291 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.119444e-02 | 1.291 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.119444e-02 | 1.291 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 5.119444e-02 | 1.291 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.144498e-02 | 1.289 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.172467e-02 | 1.286 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.172467e-02 | 1.286 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.172467e-02 | 1.286 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.172467e-02 | 1.286 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.172467e-02 | 1.286 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.293369e-02 | 1.276 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.293369e-02 | 1.276 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.293369e-02 | 1.276 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.293369e-02 | 1.276 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.293369e-02 | 1.276 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.293369e-02 | 1.276 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.416288e-02 | 1.266 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 5.516042e-02 | 1.258 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.516042e-02 | 1.258 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.516042e-02 | 1.258 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.641220e-02 | 1.249 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.641220e-02 | 1.249 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.686484e-02 | 1.245 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.863810e-02 | 1.232 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.905114e-02 | 1.229 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.928709e-02 | 1.227 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.928709e-02 | 1.227 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.928709e-02 | 1.227 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.928709e-02 | 1.227 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.061475e-02 | 1.217 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.061475e-02 | 1.217 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.061475e-02 | 1.217 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.061475e-02 | 1.217 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.061475e-02 | 1.217 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.090296e-02 | 1.215 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.126250e-02 | 1.213 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.126250e-02 | 1.213 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.497702e-02 | 1.187 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.595861e-02 | 1.181 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.595861e-02 | 1.181 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.595861e-02 | 1.181 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.595861e-02 | 1.181 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.726777e-02 | 1.172 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.726777e-02 | 1.172 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.744308e-02 | 1.171 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.771882e-02 | 1.169 | 1 | 1 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.784280e-02 | 1.168 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.784280e-02 | 1.168 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.821969e-02 | 1.166 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.852041e-02 | 1.164 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.876422e-02 | 1.163 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.045497e-02 | 1.152 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.154254e-02 | 1.145 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.224866e-02 | 1.141 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.260745e-02 | 1.139 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.260745e-02 | 1.139 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.357516e-02 | 1.133 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.580115e-02 | 1.120 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.696759e-02 | 1.114 | 1 | 1 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.704164e-02 | 1.113 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.704164e-02 | 1.113 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.704164e-02 | 1.113 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.708935e-02 | 1.113 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.711896e-02 | 1.113 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.711896e-02 | 1.113 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.780537e-02 | 1.109 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.842374e-02 | 1.106 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.842374e-02 | 1.106 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.945134e-02 | 1.100 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.063302e-02 | 1.093 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.063302e-02 | 1.093 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 8.063302e-02 | 1.093 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.063302e-02 | 1.093 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.226065e-02 | 1.085 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.268811e-02 | 1.083 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.268811e-02 | 1.083 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 8.268811e-02 | 1.083 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.294952e-02 | 1.081 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.438849e-02 | 1.074 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.438849e-02 | 1.074 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.438849e-02 | 1.074 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.446417e-02 | 1.073 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.589332e-02 | 1.066 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.618162e-02 | 1.065 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.676106e-02 | 1.062 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 9.049609e-02 | 1.043 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 9.049609e-02 | 1.043 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.322540e-02 | 1.030 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.322540e-02 | 1.030 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.324239e-02 | 1.030 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 9.324239e-02 | 1.030 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.324239e-02 | 1.030 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.324239e-02 | 1.030 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.324239e-02 | 1.030 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.346200e-02 | 1.029 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.593979e-02 | 1.018 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.593979e-02 | 1.018 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.758239e-02 | 1.011 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.758239e-02 | 1.011 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.783392e-02 | 1.010 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.833402e-02 | 1.007 | 1 | 1 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.833402e-02 | 1.007 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.833402e-02 | 1.007 | 1 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 9.863719e-02 | 1.006 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.932970e-02 | 1.003 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.932970e-02 | 1.003 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.012833e-01 | 0.994 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.012833e-01 | 0.994 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.050932e-01 | 0.978 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.050932e-01 | 0.978 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.051745e-01 | 0.978 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.083442e-01 | 0.965 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.092605e-01 | 0.962 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.092605e-01 | 0.962 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.092605e-01 | 0.962 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.092605e-01 | 0.962 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.092605e-01 | 0.962 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.093830e-01 | 0.961 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.093830e-01 | 0.961 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.093830e-01 | 0.961 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.177326e-01 | 0.929 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.177326e-01 | 0.929 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.177326e-01 | 0.929 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.177326e-01 | 0.929 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.177326e-01 | 0.929 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.216102e-01 | 0.654 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.216102e-01 | 0.654 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.216102e-01 | 0.654 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.216102e-01 | 0.654 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.216102e-01 | 0.654 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.216102e-01 | 0.654 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.216102e-01 | 0.654 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.216102e-01 | 0.654 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.216102e-01 | 0.654 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 2.216102e-01 | 0.654 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 2.216102e-01 | 0.654 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.216102e-01 | 0.654 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.216102e-01 | 0.654 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.216102e-01 | 0.654 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.216102e-01 | 0.654 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.306094e-01 | 0.884 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.306094e-01 | 0.884 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.738868e-01 | 0.760 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.738868e-01 | 0.760 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.738868e-01 | 0.760 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.738868e-01 | 0.760 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.738868e-01 | 0.760 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.738868e-01 | 0.760 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.738868e-01 | 0.760 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.738868e-01 | 0.760 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.320541e-01 | 0.879 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.320541e-01 | 0.879 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.320541e-01 | 0.879 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.190281e-01 | 0.660 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.190281e-01 | 0.660 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.190281e-01 | 0.660 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.611166e-01 | 0.793 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.611166e-01 | 0.793 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.435273e-01 | 0.843 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.435273e-01 | 0.843 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.435273e-01 | 0.843 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.918786e-01 | 0.717 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.918786e-01 | 0.717 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.918786e-01 | 0.717 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.267793e-01 | 0.897 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.267793e-01 | 0.897 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.267793e-01 | 0.897 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.668520e-01 | 0.778 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.668520e-01 | 0.778 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.668520e-01 | 0.778 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.668520e-01 | 0.778 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.453511e-01 | 0.838 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.453511e-01 | 0.838 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.270122e-01 | 0.896 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.914066e-01 | 0.718 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.113225e-01 | 0.953 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.431636e-01 | 0.844 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.431636e-01 | 0.844 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.248250e-01 | 0.904 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.170036e-01 | 0.664 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.170036e-01 | 0.664 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.541602e-01 | 0.812 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.541602e-01 | 0.812 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.541602e-01 | 0.812 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.071608e-01 | 0.684 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.699182e-01 | 0.770 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.159975e-01 | 0.666 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.460308e-01 | 0.836 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.386843e-01 | 0.858 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.580831e-01 | 0.801 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.497098e-01 | 0.825 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.210072e-01 | 0.656 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.657304e-01 | 0.781 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.316287e-01 | 0.881 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.699182e-01 | 0.770 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.431636e-01 | 0.844 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.537269e-01 | 0.813 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.118028e-01 | 0.952 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.555377e-01 | 0.808 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.650069e-01 | 0.782 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.126795e-01 | 0.948 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.749221e-01 | 0.757 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.738868e-01 | 0.760 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.270122e-01 | 0.896 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.210072e-01 | 0.656 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.341844e-01 | 0.872 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.918786e-01 | 0.717 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.410139e-01 | 0.851 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.738868e-01 | 0.760 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.270122e-01 | 0.896 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.170036e-01 | 0.664 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.181794e-01 | 0.927 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.498401e-01 | 0.824 | 1 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.172898e-01 | 0.931 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.418373e-01 | 0.848 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 2.097252e-01 | 0.678 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.918786e-01 | 0.717 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.170036e-01 | 0.664 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.856460e-01 | 0.731 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.328157e-01 | 0.877 | 1 | 1 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.159975e-01 | 0.666 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.267793e-01 | 0.897 | 1 | 1 |
| Interleukin-17 signaling | R-HSA-448424 | 1.188174e-01 | 0.925 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.256672e-01 | 0.901 | 1 | 1 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.126795e-01 | 0.948 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.170036e-01 | 0.664 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.170036e-01 | 0.664 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.391158e-01 | 0.857 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.541602e-01 | 0.812 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.647200e-01 | 0.783 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.128785e-01 | 0.947 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.073616e-01 | 0.683 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.267793e-01 | 0.897 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.637146e-01 | 0.786 | 1 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.892165e-01 | 0.723 | 1 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.344698e-01 | 0.871 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.210072e-01 | 0.656 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.764087e-01 | 0.753 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.216102e-01 | 0.654 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.216102e-01 | 0.654 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.306094e-01 | 0.884 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.738868e-01 | 0.760 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.190281e-01 | 0.660 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.918786e-01 | 0.717 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.541602e-01 | 0.812 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.764087e-01 | 0.753 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.633108e-01 | 0.787 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.248250e-01 | 0.904 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.250834e-01 | 0.903 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.914066e-01 | 0.718 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.210072e-01 | 0.656 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.918786e-01 | 0.717 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.918786e-01 | 0.717 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.113225e-01 | 0.953 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.344698e-01 | 0.871 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.320541e-01 | 0.879 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.611166e-01 | 0.793 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.216143e-01 | 0.915 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.975217e-01 | 0.704 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.537269e-01 | 0.813 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.863450e-01 | 0.730 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 1.880470e-01 | 0.726 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.288622e-01 | 0.890 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 2.033921e-01 | 0.692 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.237921e-01 | 0.907 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.113133e-01 | 0.953 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.129065e-01 | 0.947 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.118028e-01 | 0.952 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.668520e-01 | 0.778 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.193191e-01 | 0.923 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.617258e-01 | 0.791 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.918786e-01 | 0.717 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.074302e-01 | 0.683 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.853508e-01 | 0.732 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.071608e-01 | 0.684 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.236922e-01 | 0.650 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 2.236922e-01 | 0.650 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 2.239489e-01 | 0.650 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.239489e-01 | 0.650 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.239489e-01 | 0.650 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.245571e-01 | 0.649 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.248729e-01 | 0.648 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.260793e-01 | 0.646 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.291763e-01 | 0.640 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.294395e-01 | 0.639 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.294395e-01 | 0.639 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.294395e-01 | 0.639 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 2.321283e-01 | 0.634 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.357651e-01 | 0.628 | 1 | 1 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.357651e-01 | 0.628 | 1 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.357651e-01 | 0.628 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.359165e-01 | 0.627 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.404003e-01 | 0.619 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.404003e-01 | 0.619 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.404003e-01 | 0.619 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.404003e-01 | 0.619 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.404170e-01 | 0.619 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.434537e-01 | 0.614 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.434537e-01 | 0.614 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.434537e-01 | 0.614 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.434537e-01 | 0.614 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.434537e-01 | 0.614 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.439973e-01 | 0.613 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.523672e-01 | 0.598 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.523672e-01 | 0.598 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.523672e-01 | 0.598 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.563681e-01 | 0.591 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.564013e-01 | 0.591 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 2.569563e-01 | 0.590 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.569563e-01 | 0.590 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.577210e-01 | 0.589 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.629341e-01 | 0.580 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.632634e-01 | 0.580 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.649952e-01 | 0.577 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.649952e-01 | 0.577 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.649952e-01 | 0.577 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.649952e-01 | 0.577 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.649952e-01 | 0.577 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.649952e-01 | 0.577 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.649952e-01 | 0.577 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.649952e-01 | 0.577 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.658361e-01 | 0.575 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.658361e-01 | 0.575 | 1 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.705703e-01 | 0.568 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.705703e-01 | 0.568 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.705703e-01 | 0.568 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.705703e-01 | 0.568 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.705703e-01 | 0.568 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.725563e-01 | 0.565 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.758289e-01 | 0.559 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.767046e-01 | 0.558 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.767046e-01 | 0.558 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.851681e-01 | 0.545 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.864489e-01 | 0.543 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.868092e-01 | 0.542 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.905559e-01 | 0.537 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.905559e-01 | 0.537 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 2.905559e-01 | 0.537 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 2.905559e-01 | 0.537 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.905559e-01 | 0.537 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 2.905559e-01 | 0.537 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.927612e-01 | 0.533 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.960275e-01 | 0.529 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.960275e-01 | 0.529 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.963400e-01 | 0.528 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.981720e-01 | 0.526 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.981720e-01 | 0.526 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.981720e-01 | 0.526 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.985517e-01 | 0.525 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.997098e-01 | 0.523 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.057469e-01 | 0.515 | 1 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.109684e-01 | 0.507 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.109684e-01 | 0.507 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.109684e-01 | 0.507 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.109684e-01 | 0.507 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.109684e-01 | 0.507 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.109684e-01 | 0.507 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.109684e-01 | 0.507 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.109684e-01 | 0.507 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.109684e-01 | 0.507 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.128162e-01 | 0.505 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.132627e-01 | 0.504 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.132627e-01 | 0.504 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.132627e-01 | 0.504 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.132627e-01 | 0.504 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.132627e-01 | 0.504 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.132627e-01 | 0.504 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.132627e-01 | 0.504 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.132627e-01 | 0.504 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.132627e-01 | 0.504 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.132627e-01 | 0.504 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.132627e-01 | 0.504 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.132627e-01 | 0.504 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.132627e-01 | 0.504 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.132627e-01 | 0.504 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.132627e-01 | 0.504 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.132627e-01 | 0.504 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.132627e-01 | 0.504 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.134783e-01 | 0.504 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.238980e-01 | 0.490 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.244335e-01 | 0.489 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.244335e-01 | 0.489 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.244335e-01 | 0.489 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.244335e-01 | 0.489 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.244335e-01 | 0.489 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.244335e-01 | 0.489 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.244335e-01 | 0.489 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.244335e-01 | 0.489 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.244335e-01 | 0.489 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 3.244335e-01 | 0.489 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.244335e-01 | 0.489 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.260853e-01 | 0.487 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.260853e-01 | 0.487 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.260853e-01 | 0.487 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.260853e-01 | 0.487 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.354544e-01 | 0.474 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.384819e-01 | 0.470 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.400200e-01 | 0.468 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.475164e-01 | 0.459 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.475164e-01 | 0.459 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.482848e-01 | 0.458 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.482848e-01 | 0.458 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.482848e-01 | 0.458 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.482848e-01 | 0.458 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.541465e-01 | 0.451 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.541465e-01 | 0.451 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.541465e-01 | 0.451 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.554410e-01 | 0.449 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.563094e-01 | 0.448 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.563094e-01 | 0.448 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.563094e-01 | 0.448 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.563094e-01 | 0.448 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.563094e-01 | 0.448 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.563094e-01 | 0.448 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.563094e-01 | 0.448 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.563094e-01 | 0.448 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.563094e-01 | 0.448 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.563094e-01 | 0.448 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.563094e-01 | 0.448 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.563094e-01 | 0.448 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.563094e-01 | 0.448 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.569363e-01 | 0.447 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.583073e-01 | 0.446 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 3.583073e-01 | 0.446 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 3.583073e-01 | 0.446 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 3.583073e-01 | 0.446 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.638434e-01 | 0.439 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.638434e-01 | 0.439 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.638434e-01 | 0.439 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.660850e-01 | 0.436 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.662901e-01 | 0.436 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.727661e-01 | 0.429 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.727661e-01 | 0.429 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.755330e-01 | 0.425 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.755330e-01 | 0.425 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.822033e-01 | 0.418 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.822033e-01 | 0.418 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 3.822033e-01 | 0.418 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.838249e-01 | 0.416 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.885124e-01 | 0.411 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.919285e-01 | 0.407 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.919285e-01 | 0.407 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 3.919285e-01 | 0.407 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.919285e-01 | 0.407 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 3.919285e-01 | 0.407 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 3.919285e-01 | 0.407 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.927051e-01 | 0.406 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.941282e-01 | 0.404 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.941282e-01 | 0.404 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.941282e-01 | 0.404 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.941282e-01 | 0.404 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.941282e-01 | 0.404 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.941282e-01 | 0.404 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.941282e-01 | 0.404 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 3.941282e-01 | 0.404 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.941282e-01 | 0.404 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.941282e-01 | 0.404 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.941282e-01 | 0.404 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.941282e-01 | 0.404 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.941282e-01 | 0.404 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.941282e-01 | 0.404 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.941282e-01 | 0.404 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.941282e-01 | 0.404 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.941282e-01 | 0.404 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.972430e-01 | 0.401 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.972430e-01 | 0.401 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.972430e-01 | 0.401 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.981392e-01 | 0.400 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.005300e-01 | 0.397 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.005300e-01 | 0.397 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.005300e-01 | 0.397 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.005300e-01 | 0.397 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.005300e-01 | 0.397 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.005300e-01 | 0.397 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.005300e-01 | 0.397 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.005300e-01 | 0.397 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.034272e-01 | 0.394 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 4.101154e-01 | 0.387 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.101154e-01 | 0.387 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.101154e-01 | 0.387 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.101154e-01 | 0.387 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 4.101154e-01 | 0.387 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 4.101154e-01 | 0.387 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.124892e-01 | 0.385 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.158133e-01 | 0.381 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.195303e-01 | 0.377 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.250812e-01 | 0.372 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 4.250812e-01 | 0.372 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.258814e-01 | 0.371 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.295671e-01 | 0.367 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.432656e-01 | 0.353 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.432656e-01 | 0.353 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.432656e-01 | 0.353 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.432656e-01 | 0.353 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.432656e-01 | 0.353 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.432656e-01 | 0.353 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.432656e-01 | 0.353 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.447310e-01 | 0.352 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.458198e-01 | 0.351 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.458198e-01 | 0.351 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.515390e-01 | 0.345 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.515390e-01 | 0.345 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.575808e-01 | 0.340 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 4.575808e-01 | 0.340 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 4.575808e-01 | 0.340 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.575808e-01 | 0.340 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.575808e-01 | 0.340 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.602364e-01 | 0.337 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.650094e-01 | 0.333 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.654757e-01 | 0.332 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.654757e-01 | 0.332 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.654757e-01 | 0.332 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.654757e-01 | 0.332 | 1 | 1 |
| MET activates PTPN11 | R-HSA-8865999 | 4.654757e-01 | 0.332 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.654757e-01 | 0.332 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.654757e-01 | 0.332 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.654757e-01 | 0.332 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.654757e-01 | 0.332 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.654757e-01 | 0.332 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.654757e-01 | 0.332 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.654757e-01 | 0.332 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.654757e-01 | 0.332 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.697539e-01 | 0.328 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.719293e-01 | 0.326 | 1 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.725019e-01 | 0.326 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.746687e-01 | 0.324 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.757036e-01 | 0.323 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.789763e-01 | 0.320 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.842528e-01 | 0.315 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.842528e-01 | 0.315 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.842528e-01 | 0.315 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.842528e-01 | 0.315 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.842528e-01 | 0.315 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.842528e-01 | 0.315 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.842528e-01 | 0.315 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 4.848209e-01 | 0.314 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.892725e-01 | 0.310 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.917756e-01 | 0.308 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.933530e-01 | 0.307 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.147378e-01 | 0.288 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.155217e-01 | 0.288 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.155217e-01 | 0.288 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 5.165519e-01 | 0.287 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.179657e-01 | 0.286 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.179657e-01 | 0.286 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.200292e-01 | 0.284 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.200292e-01 | 0.284 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.200292e-01 | 0.284 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.200292e-01 | 0.284 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.200292e-01 | 0.284 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.222992e-01 | 0.282 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.233109e-01 | 0.281 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.233109e-01 | 0.281 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.233109e-01 | 0.281 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.233109e-01 | 0.281 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.233109e-01 | 0.281 | 0 | 0 |
| Alternative complement activation | R-HSA-173736 | 5.284250e-01 | 0.277 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.284250e-01 | 0.277 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.284250e-01 | 0.277 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.284250e-01 | 0.277 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.284250e-01 | 0.277 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.284250e-01 | 0.277 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.284250e-01 | 0.277 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.284250e-01 | 0.277 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.284250e-01 | 0.277 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.284250e-01 | 0.277 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.284250e-01 | 0.277 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.284250e-01 | 0.277 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.284250e-01 | 0.277 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 5.284250e-01 | 0.277 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.338656e-01 | 0.273 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.338656e-01 | 0.273 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.392922e-01 | 0.268 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.435036e-01 | 0.265 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.435036e-01 | 0.265 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 5.435036e-01 | 0.265 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 5.435036e-01 | 0.265 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 5.435036e-01 | 0.265 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 5.435036e-01 | 0.265 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.470751e-01 | 0.262 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.497491e-01 | 0.260 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.497491e-01 | 0.260 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.497491e-01 | 0.260 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.497491e-01 | 0.260 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.497491e-01 | 0.260 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.497491e-01 | 0.260 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.497491e-01 | 0.260 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 5.526870e-01 | 0.258 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.572288e-01 | 0.254 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 5.603259e-01 | 0.252 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.603259e-01 | 0.252 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.603259e-01 | 0.252 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.605230e-01 | 0.251 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.615228e-01 | 0.251 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.683252e-01 | 0.245 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 5.683252e-01 | 0.245 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 5.683252e-01 | 0.245 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.764255e-01 | 0.239 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 5.783537e-01 | 0.238 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.783537e-01 | 0.238 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.783537e-01 | 0.238 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 5.783537e-01 | 0.238 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.783537e-01 | 0.238 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.783537e-01 | 0.238 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 5.783537e-01 | 0.238 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.783537e-01 | 0.238 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 5.783537e-01 | 0.238 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.831993e-01 | 0.234 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.831993e-01 | 0.234 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.839641e-01 | 0.234 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.839641e-01 | 0.234 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.839641e-01 | 0.234 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.839641e-01 | 0.234 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.839641e-01 | 0.234 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.839641e-01 | 0.234 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 5.839641e-01 | 0.234 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.839641e-01 | 0.234 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.839641e-01 | 0.234 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.839641e-01 | 0.234 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.839641e-01 | 0.234 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.839641e-01 | 0.234 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.839641e-01 | 0.234 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.839641e-01 | 0.234 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 5.839641e-01 | 0.234 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.839641e-01 | 0.234 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 5.839641e-01 | 0.234 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.882921e-01 | 0.230 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 5.909973e-01 | 0.228 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.923775e-01 | 0.227 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.923775e-01 | 0.227 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 5.923775e-01 | 0.227 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.952372e-01 | 0.225 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.952372e-01 | 0.225 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.952372e-01 | 0.225 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.952372e-01 | 0.225 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.952372e-01 | 0.225 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.958590e-01 | 0.225 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.006985e-01 | 0.221 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.057848e-01 | 0.218 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.057848e-01 | 0.218 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.057848e-01 | 0.218 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.148077e-01 | 0.211 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.156181e-01 | 0.211 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.156181e-01 | 0.211 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.176366e-01 | 0.209 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.245335e-01 | 0.204 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.247449e-01 | 0.204 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.280269e-01 | 0.202 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.280269e-01 | 0.202 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.280269e-01 | 0.202 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.280269e-01 | 0.202 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.280269e-01 | 0.202 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.280269e-01 | 0.202 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 6.280269e-01 | 0.202 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 6.320028e-01 | 0.199 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.320028e-01 | 0.199 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.329651e-01 | 0.199 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.329651e-01 | 0.199 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.329651e-01 | 0.199 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.329651e-01 | 0.199 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.329651e-01 | 0.199 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.329651e-01 | 0.199 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.329651e-01 | 0.199 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.329651e-01 | 0.199 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.329651e-01 | 0.199 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.329651e-01 | 0.199 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.329651e-01 | 0.199 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.329651e-01 | 0.199 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.329651e-01 | 0.199 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 6.329651e-01 | 0.199 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.329651e-01 | 0.199 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.329651e-01 | 0.199 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.330762e-01 | 0.199 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.332475e-01 | 0.198 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.347814e-01 | 0.197 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.365654e-01 | 0.196 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.380140e-01 | 0.195 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.380140e-01 | 0.195 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 6.404129e-01 | 0.194 | 1 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.412105e-01 | 0.193 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.445568e-01 | 0.191 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.478175e-01 | 0.189 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.487071e-01 | 0.188 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 6.506226e-01 | 0.187 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.559757e-01 | 0.183 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.569842e-01 | 0.182 | 1 | 1 |
| Attachment and Entry | R-HSA-9694614 | 6.569842e-01 | 0.182 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.569842e-01 | 0.182 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.569842e-01 | 0.182 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.587105e-01 | 0.181 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.587105e-01 | 0.181 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.587105e-01 | 0.181 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 6.595416e-01 | 0.181 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.595416e-01 | 0.181 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.595416e-01 | 0.181 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.595416e-01 | 0.181 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.636993e-01 | 0.178 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.685226e-01 | 0.175 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.736145e-01 | 0.172 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 6.761972e-01 | 0.170 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.761972e-01 | 0.170 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.761972e-01 | 0.170 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.761972e-01 | 0.170 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.761972e-01 | 0.170 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.761972e-01 | 0.170 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.761972e-01 | 0.170 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.761972e-01 | 0.170 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.761972e-01 | 0.170 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.761972e-01 | 0.170 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.761972e-01 | 0.170 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.801851e-01 | 0.167 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.807192e-01 | 0.167 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.807192e-01 | 0.167 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.807192e-01 | 0.167 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.807192e-01 | 0.167 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.807997e-01 | 0.167 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.821577e-01 | 0.166 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.873292e-01 | 0.163 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.873292e-01 | 0.163 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.873292e-01 | 0.163 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 6.906209e-01 | 0.161 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.924413e-01 | 0.160 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.974714e-01 | 0.156 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.999220e-01 | 0.155 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.999220e-01 | 0.155 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.015664e-01 | 0.154 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.015664e-01 | 0.154 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.032103e-01 | 0.153 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.032103e-01 | 0.153 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.032103e-01 | 0.153 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.139436e-01 | 0.146 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 7.139436e-01 | 0.146 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 7.139436e-01 | 0.146 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 7.139436e-01 | 0.146 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 7.139436e-01 | 0.146 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.139436e-01 | 0.146 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.139436e-01 | 0.146 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.139436e-01 | 0.146 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.139436e-01 | 0.146 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.143394e-01 | 0.146 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.143394e-01 | 0.146 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.143394e-01 | 0.146 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.143394e-01 | 0.146 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 7.143394e-01 | 0.146 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.143394e-01 | 0.146 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.143394e-01 | 0.146 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.143394e-01 | 0.146 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.143394e-01 | 0.146 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 7.169864e-01 | 0.144 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.172297e-01 | 0.144 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.186577e-01 | 0.143 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.187927e-01 | 0.143 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.208084e-01 | 0.142 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.244700e-01 | 0.140 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.244700e-01 | 0.140 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.244700e-01 | 0.140 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.244700e-01 | 0.140 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.293954e-01 | 0.137 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.293954e-01 | 0.137 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.323150e-01 | 0.135 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.326949e-01 | 0.135 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.326949e-01 | 0.135 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 7.327645e-01 | 0.135 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.333493e-01 | 0.135 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.333493e-01 | 0.135 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.333493e-01 | 0.135 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 7.333493e-01 | 0.135 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.358193e-01 | 0.133 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.358193e-01 | 0.133 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.367589e-01 | 0.133 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.367589e-01 | 0.133 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.378647e-01 | 0.132 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.386287e-01 | 0.132 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 7.386287e-01 | 0.132 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 7.386287e-01 | 0.132 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 7.386287e-01 | 0.132 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.386287e-01 | 0.132 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.386287e-01 | 0.132 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.445195e-01 | 0.128 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.445195e-01 | 0.128 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.445195e-01 | 0.128 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.445195e-01 | 0.128 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.445195e-01 | 0.128 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 7.462387e-01 | 0.127 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.468216e-01 | 0.127 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.479905e-01 | 0.126 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.479905e-01 | 0.126 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.479905e-01 | 0.126 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.479905e-01 | 0.126 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.479905e-01 | 0.126 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.479905e-01 | 0.126 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.479905e-01 | 0.126 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.479905e-01 | 0.126 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.479905e-01 | 0.126 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.479905e-01 | 0.126 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.479905e-01 | 0.126 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.479905e-01 | 0.126 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 7.479905e-01 | 0.126 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.479905e-01 | 0.126 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.479905e-01 | 0.126 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.479905e-01 | 0.126 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.479905e-01 | 0.126 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 7.479905e-01 | 0.126 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.479905e-01 | 0.126 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.494710e-01 | 0.125 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.514355e-01 | 0.124 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.538437e-01 | 0.123 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.538437e-01 | 0.123 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.538437e-01 | 0.123 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.607511e-01 | 0.119 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.614697e-01 | 0.118 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.614697e-01 | 0.118 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.614697e-01 | 0.118 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.633867e-01 | 0.117 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.633867e-01 | 0.117 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.633867e-01 | 0.117 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.639824e-01 | 0.117 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.639824e-01 | 0.117 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.700605e-01 | 0.113 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.700605e-01 | 0.113 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.718480e-01 | 0.112 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.718480e-01 | 0.112 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.718480e-01 | 0.112 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.744465e-01 | 0.111 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.776793e-01 | 0.109 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.776793e-01 | 0.109 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.776793e-01 | 0.109 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.776793e-01 | 0.109 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.776793e-01 | 0.109 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.776793e-01 | 0.109 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.776793e-01 | 0.109 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.776793e-01 | 0.109 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.776793e-01 | 0.109 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.776793e-01 | 0.109 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.795693e-01 | 0.108 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.811056e-01 | 0.107 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.822929e-01 | 0.107 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.825584e-01 | 0.106 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.825584e-01 | 0.106 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.854265e-01 | 0.105 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.854265e-01 | 0.105 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.918745e-01 | 0.101 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.918745e-01 | 0.101 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.918745e-01 | 0.101 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.977143e-01 | 0.098 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.977143e-01 | 0.098 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.977143e-01 | 0.098 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.977143e-01 | 0.098 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.977143e-01 | 0.098 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.010650e-01 | 0.096 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.019906e-01 | 0.096 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.019906e-01 | 0.096 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.019906e-01 | 0.096 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.019906e-01 | 0.096 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.038720e-01 | 0.095 | 0 | 0 |
| OADH complex synthesizes glutaryl-CoA from 2-OA | R-HSA-9858328 | 8.038720e-01 | 0.095 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.038720e-01 | 0.095 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 8.038720e-01 | 0.095 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 8.038720e-01 | 0.095 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 8.038720e-01 | 0.095 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.038720e-01 | 0.095 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 8.038720e-01 | 0.095 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.048210e-01 | 0.094 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.048210e-01 | 0.094 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.132546e-01 | 0.090 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.136901e-01 | 0.090 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.198638e-01 | 0.086 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.219490e-01 | 0.085 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.266357e-01 | 0.083 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.266357e-01 | 0.083 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.267443e-01 | 0.083 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.267443e-01 | 0.083 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.267443e-01 | 0.083 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.269802e-01 | 0.083 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.269802e-01 | 0.083 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.269802e-01 | 0.083 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.269802e-01 | 0.083 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.269802e-01 | 0.083 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.269802e-01 | 0.083 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.269802e-01 | 0.083 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.274367e-01 | 0.082 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.277706e-01 | 0.082 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.277706e-01 | 0.082 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.287888e-01 | 0.082 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.335998e-01 | 0.079 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.336630e-01 | 0.079 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.362756e-01 | 0.078 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.362756e-01 | 0.078 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.388259e-01 | 0.076 | 1 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.388259e-01 | 0.076 | 1 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.413083e-01 | 0.075 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.426637e-01 | 0.074 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.426637e-01 | 0.074 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.444903e-01 | 0.073 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.451341e-01 | 0.073 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.473669e-01 | 0.072 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 8.473669e-01 | 0.072 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.473669e-01 | 0.072 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.473669e-01 | 0.072 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.473669e-01 | 0.072 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.473669e-01 | 0.072 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.473669e-01 | 0.072 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.473669e-01 | 0.072 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.503067e-01 | 0.070 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.503067e-01 | 0.070 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.513221e-01 | 0.070 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.513221e-01 | 0.070 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 8.513221e-01 | 0.070 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.539145e-01 | 0.069 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.610527e-01 | 0.065 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.610527e-01 | 0.065 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.613790e-01 | 0.065 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.650972e-01 | 0.063 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.650972e-01 | 0.063 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.650972e-01 | 0.063 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.650972e-01 | 0.063 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.650972e-01 | 0.063 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.650972e-01 | 0.063 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 8.650972e-01 | 0.063 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.653525e-01 | 0.063 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.653525e-01 | 0.063 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.653525e-01 | 0.063 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.653525e-01 | 0.063 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.653525e-01 | 0.063 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.653525e-01 | 0.063 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.653525e-01 | 0.063 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.653525e-01 | 0.063 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.653525e-01 | 0.063 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.656364e-01 | 0.063 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 8.700239e-01 | 0.060 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.711480e-01 | 0.060 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.711480e-01 | 0.060 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.765215e-01 | 0.057 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.765215e-01 | 0.057 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.775126e-01 | 0.057 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.776915e-01 | 0.057 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.776915e-01 | 0.057 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.776915e-01 | 0.057 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.776915e-01 | 0.057 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 8.776915e-01 | 0.057 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.776915e-01 | 0.057 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.783316e-01 | 0.056 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.794049e-01 | 0.056 | 0 | 0 |
| OGDH complex synthesizes succinyl-CoA from 2-OG | R-HSA-9853506 | 8.812197e-01 | 0.055 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.812197e-01 | 0.055 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.812197e-01 | 0.055 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.812197e-01 | 0.055 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.812197e-01 | 0.055 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.859666e-01 | 0.053 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.859666e-01 | 0.053 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.866163e-01 | 0.052 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.891919e-01 | 0.051 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.891919e-01 | 0.051 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.891919e-01 | 0.051 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.894516e-01 | 0.051 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.932966e-01 | 0.049 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.935389e-01 | 0.049 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.952179e-01 | 0.048 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.952179e-01 | 0.048 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.952179e-01 | 0.048 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.952179e-01 | 0.048 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.952179e-01 | 0.048 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.952179e-01 | 0.048 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.952179e-01 | 0.048 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.952179e-01 | 0.048 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.952179e-01 | 0.048 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.952179e-01 | 0.048 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.959667e-01 | 0.048 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.977196e-01 | 0.047 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.996813e-01 | 0.046 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.996813e-01 | 0.046 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.996813e-01 | 0.046 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.012506e-01 | 0.045 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.067556e-01 | 0.043 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.075671e-01 | 0.042 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.075671e-01 | 0.042 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.075671e-01 | 0.042 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.075671e-01 | 0.042 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.075671e-01 | 0.042 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.075671e-01 | 0.042 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 9.075671e-01 | 0.042 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.086412e-01 | 0.042 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.092382e-01 | 0.041 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.092382e-01 | 0.041 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.179367e-01 | 0.037 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.182869e-01 | 0.037 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.184615e-01 | 0.037 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.184615e-01 | 0.037 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.184615e-01 | 0.037 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.184615e-01 | 0.037 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.184615e-01 | 0.037 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.184615e-01 | 0.037 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.184615e-01 | 0.037 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.199927e-01 | 0.036 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.234337e-01 | 0.035 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.258462e-01 | 0.033 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.258462e-01 | 0.033 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.258462e-01 | 0.033 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.258462e-01 | 0.033 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.278054e-01 | 0.033 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.280725e-01 | 0.032 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.280725e-01 | 0.032 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.280725e-01 | 0.032 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.280725e-01 | 0.032 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.280725e-01 | 0.032 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.280725e-01 | 0.032 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.280725e-01 | 0.032 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.280725e-01 | 0.032 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.321245e-01 | 0.031 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.330319e-01 | 0.030 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.365511e-01 | 0.028 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.365511e-01 | 0.028 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.365511e-01 | 0.028 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.365511e-01 | 0.028 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.365511e-01 | 0.028 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.365511e-01 | 0.028 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.395546e-01 | 0.027 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.395546e-01 | 0.027 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.399075e-01 | 0.027 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.417102e-01 | 0.026 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.417736e-01 | 0.026 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.430933e-01 | 0.025 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.440307e-01 | 0.025 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.440307e-01 | 0.025 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.440307e-01 | 0.025 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.440307e-01 | 0.025 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.440307e-01 | 0.025 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.440307e-01 | 0.025 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.441506e-01 | 0.025 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.490282e-01 | 0.023 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.506289e-01 | 0.022 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.506289e-01 | 0.022 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.520133e-01 | 0.021 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.556879e-01 | 0.020 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.564496e-01 | 0.019 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.564496e-01 | 0.019 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.564496e-01 | 0.019 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.564496e-01 | 0.019 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.567911e-01 | 0.019 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.574316e-01 | 0.019 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.584964e-01 | 0.018 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.584964e-01 | 0.018 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.600825e-01 | 0.018 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.600825e-01 | 0.018 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.604897e-01 | 0.018 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.615844e-01 | 0.017 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.615844e-01 | 0.017 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.615844e-01 | 0.017 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.615844e-01 | 0.017 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.638222e-01 | 0.016 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.640572e-01 | 0.016 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.640572e-01 | 0.016 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.640572e-01 | 0.016 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.661141e-01 | 0.015 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.661141e-01 | 0.015 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.661141e-01 | 0.015 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.663862e-01 | 0.015 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.664879e-01 | 0.015 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.676498e-01 | 0.014 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.701098e-01 | 0.013 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.701098e-01 | 0.013 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.701098e-01 | 0.013 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.704913e-01 | 0.013 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.704913e-01 | 0.013 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.704913e-01 | 0.013 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.704913e-01 | 0.013 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.708217e-01 | 0.013 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.708952e-01 | 0.013 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.708952e-01 | 0.013 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.735156e-01 | 0.012 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.735156e-01 | 0.012 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.736346e-01 | 0.012 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.736346e-01 | 0.012 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.736544e-01 | 0.012 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.738253e-01 | 0.012 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.764694e-01 | 0.010 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.767439e-01 | 0.010 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.767439e-01 | 0.010 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.767439e-01 | 0.010 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.767439e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.794867e-01 | 0.009 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.794867e-01 | 0.009 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.794867e-01 | 0.009 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.810036e-01 | 0.008 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.810036e-01 | 0.008 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.810036e-01 | 0.008 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.819062e-01 | 0.008 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.819062e-01 | 0.008 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.819062e-01 | 0.008 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.829405e-01 | 0.007 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.840404e-01 | 0.007 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.840404e-01 | 0.007 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.840404e-01 | 0.007 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.840404e-01 | 0.007 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.840515e-01 | 0.007 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.846849e-01 | 0.007 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.851625e-01 | 0.006 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.875836e-01 | 0.005 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.875836e-01 | 0.005 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.875836e-01 | 0.005 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.878079e-01 | 0.005 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.884171e-01 | 0.005 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.889395e-01 | 0.005 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.889788e-01 | 0.005 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.889788e-01 | 0.005 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.895443e-01 | 0.005 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.899965e-01 | 0.004 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.903405e-01 | 0.004 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.903405e-01 | 0.004 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.909435e-01 | 0.004 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.914802e-01 | 0.004 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.916465e-01 | 0.004 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.918037e-01 | 0.004 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.919086e-01 | 0.004 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.924855e-01 | 0.003 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.924855e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.928617e-01 | 0.003 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.933722e-01 | 0.003 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.933722e-01 | 0.003 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.937113e-01 | 0.003 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.941543e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.942560e-01 | 0.003 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.943680e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.948442e-01 | 0.002 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.948442e-01 | 0.002 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.948738e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.948738e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.950479e-01 | 0.002 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.954527e-01 | 0.002 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.954527e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.955267e-01 | 0.002 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.956778e-01 | 0.002 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.959894e-01 | 0.002 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.959894e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.959894e-01 | 0.002 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.959894e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.959894e-01 | 0.002 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.960668e-01 | 0.002 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.960668e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.964628e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.967085e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.967451e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.968803e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.969117e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.970240e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.975734e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.981126e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.981279e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.983355e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.983355e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.983355e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.985320e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.985320e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.985643e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.987054e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.987054e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.988025e-01 | 0.001 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.988057e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.988335e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.988345e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.989931e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.989931e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.989976e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.992417e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.992568e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.993055e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.993094e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.993100e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.993295e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.994104e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.994216e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.994501e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.994615e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.994615e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.995824e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.996007e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.996114e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.996114e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.996595e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.996752e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.997649e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.997773e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998295e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.998654e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.998813e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999149e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.999186e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999218e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999271e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999275e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999282e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999508e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999508e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999566e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999566e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999663e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999698e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999770e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999796e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999818e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999820e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999820e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999821e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999856e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999904e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999928e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999934e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999936e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999975e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999984e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999994e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999995e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999996e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |